This pipeline computes the correlation between cancer subtypes identified by different molecular patterns and selected clinical features.
Testing the association between subtypes identified by 10 different clustering approaches and 39 clinical features across 307 patients, 76 significant findings detected with P value < 0.05 and Q value < 0.25.
-
5 subtypes identified in current cancer cohort by 'Copy Number Ratio CNMF subtypes'. These subtypes correlate to 'YEARS_TO_BIRTH', 'PATHOLOGY_T_STAGE', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', 'NUMBER_OF_LYMPH_NODES', 'NEOPLASM_HISTOLOGIC_GRADE', 'LYMPH_NODES_EXAMINED_HE_COUNT', 'AGE_AT_DIAGNOSIS', and 'CLINICAL_STAGE'.
-
3 subtypes identified in current cancer cohort by 'METHLYATION CNMF'. These subtypes correlate to 'HISTOLOGICAL_TYPE', 'NUMBER_OF_LYMPH_NODES', 'PREGNANCIES_COUNT_TOTAL', 'PREGNANCIES_COUNT_LIVE_BIRTH', 'LYMPH_NODES_EXAMINED_HE_COUNT', and 'KERATINIZATION_SQUAMOUS_CELL'.
-
CNMF clustering analysis on RPPA data identified 3 subtypes that correlate to 'LYMPHOVASCULAR_INVOLVEMENT' and 'LYMPH_NODES_EXAMINED'.
-
Consensus hierarchical clustering analysis on RPPA data identified 5 subtypes that correlate to 'HISTOLOGICAL_TYPE', 'KERATINIZATION_SQUAMOUS_CELL', and 'CHEMO_CONCURRENT_TYPE'.
-
CNMF clustering analysis on sequencing-based mRNA expression data identified 4 subtypes that correlate to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'NUMBER_OF_LYMPH_NODES', 'RACE', 'NEOPLASM_HISTOLOGIC_GRADE', 'PREGNANCIES_COUNT_TOTAL', 'PREGNANCIES_COUNT_LIVE_BIRTH', 'MENOPAUSE_STATUS', 'LYMPH_NODES_EXAMINED_HE_COUNT', 'KERATINIZATION_SQUAMOUS_CELL', 'AGE_AT_DIAGNOSIS', and 'CLINICAL_STAGE'.
-
Consensus hierarchical clustering analysis on sequencing-based mRNA expression data identified 3 subtypes that correlate to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'NUMBER_OF_LYMPH_NODES', 'PREGNANCIES_COUNT_TOTAL', 'PREGNANCIES_COUNT_LIVE_BIRTH', 'MENOPAUSE_STATUS', 'LYMPH_NODES_EXAMINED_HE_COUNT', 'KERATINIZATION_SQUAMOUS_CELL', 'INITIAL_PATHOLOGIC_DX_YEAR', 'HISTORY_HORMONAL_CONTRACEPTIVES_USE', and 'AGE_AT_DIAGNOSIS'.
-
3 subtypes identified in current cancer cohort by 'MIRSEQ CNMF'. These subtypes correlate to 'HISTOLOGICAL_TYPE', 'NEOPLASM_HISTOLOGIC_GRADE', 'TOBACCO_SMOKING_HISTORY', 'PREGNANCY_SPONTANEOUS_ABORTION_COUNT', 'KERATINIZATION_SQUAMOUS_CELL', 'INITIAL_PATHOLOGIC_DX_YEAR', and 'CLINICAL_STAGE'.
-
5 subtypes identified in current cancer cohort by 'MIRSEQ CHIERARCHICAL'. These subtypes correlate to 'YEARS_TO_BIRTH', 'PATHOLOGY_T_STAGE', 'HISTOLOGICAL_TYPE', 'NEOPLASM_HISTOLOGIC_GRADE', 'PREGNANCIES_COUNT_LIVE_BIRTH', 'MENOPAUSE_STATUS', 'INITIAL_PATHOLOGIC_DX_YEAR', 'AGE_AT_DIAGNOSIS', and 'CLINICAL_STAGE'.
-
3 subtypes identified in current cancer cohort by 'MIRseq Mature CNMF subtypes'. These subtypes correlate to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'NEOPLASM_HISTOLOGIC_GRADE', 'MENOPAUSE_STATUS', 'KERATINIZATION_SQUAMOUS_CELL', 'INITIAL_PATHOLOGIC_DX_YEAR', 'AGE_AT_DIAGNOSIS', and 'CLINICAL_STAGE'.
-
5 subtypes identified in current cancer cohort by 'MIRseq Mature cHierClus subtypes'. These subtypes correlate to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'NUMBER_OF_LYMPH_NODES', 'NEOPLASM_HISTOLOGIC_GRADE', 'RADIATION_THERAPY_STATUS', 'LYMPH_NODES_EXAMINED_HE_COUNT', 'INITIAL_PATHOLOGIC_DX_YEAR', and 'AGE_AT_DIAGNOSIS'.
Clinical Features |
Statistical Tests |
Copy Number Ratio CNMF subtypes |
METHLYATION CNMF |
RPPA CNMF subtypes |
RPPA cHierClus subtypes |
RNAseq CNMF subtypes |
RNAseq cHierClus subtypes |
MIRSEQ CNMF |
MIRSEQ CHIERARCHICAL |
MIRseq Mature CNMF subtypes |
MIRseq Mature cHierClus subtypes |
Time to Death | logrank test |
0.682 (0.852) |
0.967 (0.992) |
0.0599 (0.285) |
0.183 (0.498) |
0.44 (0.723) |
0.0302 (0.199) |
0.889 (0.957) |
0.692 (0.856) |
0.779 (0.893) |
0.928 (0.98) |
YEARS TO BIRTH | Kruskal-Wallis (anova) |
0.00931 (0.114) |
0.174 (0.493) |
0.0786 (0.325) |
0.0879 (0.346) |
8.51e-06 (0.000433) |
0.00802 (0.114) |
0.619 (0.844) |
0.000125 (0.00376) |
0.0366 (0.207) |
0.00654 (0.102) |
PATHOLOGY T STAGE | Fisher's exact test |
0.0336 (0.199) |
0.422 (0.72) |
0.891 (0.957) |
0.645 (0.844) |
0.661 (0.844) |
0.704 (0.857) |
0.172 (0.493) |
0.00365 (0.0729) |
0.211 (0.541) |
0.262 (0.567) |
PATHOLOGY N STAGE | Fisher's exact test |
0.35 (0.657) |
0.232 (0.549) |
0.661 (0.844) |
0.213 (0.543) |
0.377 (0.675) |
0.349 (0.657) |
0.609 (0.844) |
0.23 (0.549) |
0.547 (0.794) |
0.0778 (0.325) |
PATHOLOGY M STAGE | Fisher's exact test |
0.736 (0.872) |
0.36 (0.661) |
0.55 (0.794) |
1 (1.00) |
0.267 (0.576) |
0.0524 (0.266) |
0.0987 (0.37) |
0.354 (0.66) |
0.114 (0.398) |
0.282 (0.601) |
RADIATION THERAPY | Fisher's exact test |
0.0136 (0.144) |
0.773 (0.891) |
0.611 (0.844) |
0.303 (0.624) |
0.888 (0.957) |
1 (1.00) |
0.955 (0.986) |
0.445 (0.726) |
0.976 (1) |
0.927 (0.98) |
HISTOLOGICAL TYPE | Fisher's exact test |
1e-05 (0.000433) |
1e-05 (0.000433) |
0.311 (0.628) |
0.00394 (0.0732) |
1e-05 (0.000433) |
1e-05 (0.000433) |
1e-05 (0.000433) |
1e-05 (0.000433) |
1e-05 (0.000433) |
1e-05 (0.000433) |
NUMBER PACK YEARS SMOKED | Kruskal-Wallis (anova) |
0.662 (0.844) |
0.112 (0.398) |
0.198 (0.515) |
0.54 (0.794) |
0.106 (0.385) |
0.437 (0.723) |
0.0659 (0.29) |
0.157 (0.474) |
0.302 (0.624) |
0.0646 (0.29) |
NUMBER OF LYMPH NODES | Kruskal-Wallis (anova) |
0.048 (0.247) |
0.0366 (0.207) |
0.632 (0.844) |
0.177 (0.493) |
0.0146 (0.146) |
0.0308 (0.199) |
0.242 (0.549) |
0.134 (0.421) |
0.478 (0.742) |
0.0318 (0.199) |
RACE | Fisher's exact test |
0.239 (0.549) |
0.273 (0.586) |
0.307 (0.628) |
0.209 (0.539) |
0.00901 (0.114) |
0.307 (0.628) |
0.217 (0.547) |
0.33 (0.647) |
0.0823 (0.327) |
0.0739 (0.313) |
ETHNICITY | Fisher's exact test |
0.225 (0.549) |
0.701 (0.857) |
0.432 (0.723) |
0.473 (0.742) |
0.255 (0.566) |
0.896 (0.957) |
0.674 (0.848) |
0.412 (0.715) |
0.24 (0.549) |
0.217 (0.547) |
WEIGHT KG AT DIAGNOSIS | Kruskal-Wallis (anova) |
0.324 (0.638) |
0.244 (0.55) |
0.0556 (0.278) |
0.542 (0.794) |
0.694 (0.856) |
0.677 (0.849) |
0.551 (0.794) |
0.933 (0.984) |
0.476 (0.742) |
0.479 (0.742) |
TUMOR STATUS | Fisher's exact test |
0.949 (0.986) |
0.561 (0.801) |
0.674 (0.848) |
0.53 (0.789) |
0.38 (0.676) |
0.425 (0.72) |
0.58 (0.814) |
0.713 (0.861) |
0.556 (0.797) |
0.642 (0.844) |
NEOPLASM HISTOLOGIC GRADE | Fisher's exact test |
0.0298 (0.199) |
0.375 (0.675) |
0.34 (0.65) |
0.551 (0.794) |
0.00049 (0.0136) |
0.157 (0.474) |
0.00417 (0.0739) |
0.0228 (0.199) |
0.00354 (0.0729) |
6e-05 (0.00213) |
TOBACCO SMOKING YEAR STOPPED | Kruskal-Wallis (anova) |
0.401 (0.698) |
0.497 (0.759) |
0.838 (0.93) |
0.706 (0.857) |
0.836 (0.93) |
0.569 (0.81) |
0.125 (0.415) |
0.147 (0.455) |
0.422 (0.72) |
0.479 (0.742) |
TOBACCO SMOKING PACK YEARS SMOKED | Kruskal-Wallis (anova) |
0.662 (0.844) |
0.112 (0.398) |
0.198 (0.515) |
0.54 (0.794) |
0.106 (0.385) |
0.437 (0.723) |
0.0659 (0.29) |
0.157 (0.474) |
0.302 (0.624) |
0.0646 (0.29) |
TOBACCO SMOKING HISTORY | Kruskal-Wallis (anova) |
0.338 (0.65) |
0.0617 (0.29) |
0.802 (0.91) |
0.471 (0.742) |
0.255 (0.566) |
0.0944 (0.364) |
0.043 (0.233) |
0.669 (0.848) |
0.444 (0.726) |
0.31 (0.628) |
AGEBEGANSMOKINGINYEARS | Kruskal-Wallis (anova) |
0.527 (0.787) |
0.715 (0.861) |
0.747 (0.88) |
0.808 (0.91) |
0.226 (0.549) |
0.655 (0.844) |
0.892 (0.957) |
0.764 (0.89) |
0.95 (0.986) |
0.4 (0.698) |
RADIATION THERAPY STATUS | Fisher's exact test |
1 (1.00) |
1 (1.00) |
0.725 (0.87) |
1 (1.00) |
0.733 (0.871) |
1 (1.00) |
0.551 (0.794) |
0.858 (0.935) |
1 (1.00) |
0.0332 (0.199) |
PREGNANCIES COUNT TOTAL | Kruskal-Wallis (anova) |
0.669 (0.848) |
0.0168 (0.16) |
0.472 (0.742) |
0.622 (0.844) |
0.0261 (0.199) |
0.0475 (0.247) |
0.506 (0.771) |
0.0673 (0.292) |
0.494 (0.759) |
0.0979 (0.37) |
PREGNANCIES COUNT STILLBIRTH | Kruskal-Wallis (anova) |
0.0563 (0.278) |
0.793 (0.904) |
0.458 (0.737) |
0.224 (0.549) |
0.164 (0.487) |
0.574 (0.81) |
0.756 (0.886) |
0.481 (0.742) |
0.756 (0.886) |
0.657 (0.844) |
PREGNANCY SPONTANEOUS ABORTION COUNT | Kruskal-Wallis (anova) |
0.951 (0.986) |
0.629 (0.844) |
0.806 (0.91) |
0.809 (0.91) |
0.772 (0.891) |
0.13 (0.415) |
0.0206 (0.187) |
0.179 (0.493) |
0.194 (0.512) |
0.159 (0.477) |
PREGNANCIES COUNT LIVE BIRTH | Kruskal-Wallis (anova) |
0.26 (0.567) |
0.0333 (0.199) |
0.124 (0.415) |
0.114 (0.398) |
0.0381 (0.209) |
0.0188 (0.174) |
0.649 (0.844) |
0.016 (0.156) |
0.957 (0.986) |
0.235 (0.549) |
PREGNANCY THERAPEUTIC ABORTION COUNT | Kruskal-Wallis (anova) |
0.854 (0.935) |
0.76 (0.887) |
0.786 (0.898) |
0.655 (0.844) |
0.815 (0.913) |
0.616 (0.844) |
0.462 (0.739) |
0.936 (0.984) |
0.188 (0.506) |
0.323 (0.638) |
PREGNANCIES COUNT ECTOPIC | Kruskal-Wallis (anova) |
0.6 (0.839) |
0.291 (0.61) |
0.919 (0.976) |
0.638 (0.844) |
0.192 (0.51) |
0.855 (0.935) |
0.338 (0.65) |
0.958 (0.986) |
0.982 (1.00) |
0.426 (0.72) |
POS LYMPH NODE LOCATION | Fisher's exact test |
0.177 (0.493) |
0.366 (0.666) |
0.366 (0.666) |
0.251 (0.562) |
0.359 (0.661) |
0.426 (0.72) |
0.0901 (0.352) |
0.428 (0.72) |
0.397 (0.697) |
0.261 (0.567) |
MENOPAUSE STATUS | Fisher's exact test |
0.241 (0.549) |
0.0814 (0.327) |
0.128 (0.415) |
0.873 (0.949) |
0.0481 (0.247) |
0.0234 (0.199) |
0.727 (0.87) |
0.0134 (0.144) |
0.012 (0.137) |
0.29 (0.61) |
LYMPHOVASCULAR INVOLVEMENT | Fisher's exact test |
0.172 (0.493) |
0.224 (0.549) |
0.0301 (0.199) |
0.425 (0.72) |
0.819 (0.915) |
0.639 (0.844) |
0.607 (0.844) |
0.378 (0.675) |
0.695 (0.856) |
0.112 (0.398) |
LYMPH NODES EXAMINED HE COUNT | Kruskal-Wallis (anova) |
0.048 (0.247) |
0.0366 (0.207) |
0.632 (0.844) |
0.177 (0.493) |
0.0146 (0.146) |
0.0308 (0.199) |
0.242 (0.549) |
0.134 (0.421) |
0.478 (0.742) |
0.0318 (0.199) |
LYMPH NODES EXAMINED | Kruskal-Wallis (anova) |
0.742 (0.877) |
0.804 (0.91) |
0.00935 (0.114) |
0.236 (0.549) |
0.174 (0.493) |
0.342 (0.65) |
0.847 (0.933) |
0.319 (0.635) |
0.642 (0.844) |
0.316 (0.634) |
KERATINIZATION SQUAMOUS CELL | Fisher's exact test |
0.524 (0.786) |
0.0271 (0.199) |
0.0795 (0.325) |
0.0376 (0.209) |
0.0321 (0.199) |
0.00374 (0.0729) |
0.0335 (0.199) |
0.123 (0.415) |
0.00884 (0.114) |
0.0641 (0.29) |
INITIAL PATHOLOGIC DX YEAR | Kruskal-Wallis (anova) |
0.63 (0.844) |
0.947 (0.986) |
0.524 (0.786) |
0.841 (0.93) |
0.347 (0.657) |
0.0135 (0.144) |
0.000899 (0.0219) |
0.0235 (0.199) |
0.00872 (0.114) |
0.0245 (0.199) |
HISTORY HORMONAL CONTRACEPTIVES USE | Fisher's exact test |
0.776 (0.892) |
0.235 (0.549) |
0.697 (0.856) |
0.552 (0.794) |
0.0953 (0.364) |
0.0336 (0.199) |
0.731 (0.871) |
0.317 (0.634) |
0.625 (0.844) |
0.662 (0.844) |
HEIGHT CM AT DIAGNOSIS | Kruskal-Wallis (anova) |
0.461 (0.739) |
0.573 (0.81) |
0.126 (0.415) |
0.167 (0.493) |
0.291 (0.61) |
0.146 (0.455) |
0.904 (0.963) |
0.686 (0.854) |
0.708 (0.857) |
0.437 (0.723) |
CORPUS INVOLVEMENT | Fisher's exact test |
0.95 (0.986) |
0.17 (0.493) |
0.127 (0.415) |
0.455 (0.737) |
0.0691 (0.296) |
0.342 (0.65) |
0.577 (0.812) |
0.339 (0.65) |
0.857 (0.935) |
0.359 (0.661) |
CHEMO CONCURRENT TYPE | Fisher's exact test |
0.259 (0.567) |
0.628 (0.844) |
0.509 (0.772) |
0.00359 (0.0729) |
0.396 (0.697) |
0.117 (0.402) |
0.841 (0.93) |
0.458 (0.737) |
0.895 (0.957) |
0.08 (0.325) |
CERVIX SUV RESULTS | Kruskal-Wallis (anova) |
0.768 (0.891) |
0.385 (0.683) |
0.0662 (0.29) |
0.231 (0.549) |
0.226 (0.549) |
0.367 (0.666) |
0.242 (0.549) |
0.18 (0.493) |
0.19 (0.509) |
|
AGE AT DIAGNOSIS | Kruskal-Wallis (anova) |
0.0112 (0.132) |
0.184 (0.498) |
0.0597 (0.285) |
0.117 (0.402) |
1.34e-05 (0.000522) |
0.00655 (0.102) |
0.698 (0.856) |
9.35e-05 (0.00304) |
0.0326 (0.199) |
0.00599 (0.102) |
CLINICAL STAGE | Fisher's exact test |
0.0246 (0.199) |
0.0591 (0.285) |
0.645 (0.844) |
0.13 (0.415) |
0.0304 (0.199) |
0.106 (0.385) |
0.00923 (0.114) |
0.00075 (0.0195) |
0.0295 (0.199) |
0.514 (0.778) |
Cluster Labels | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Number of samples | 15 | 112 | 56 | 59 | 53 |
P value = 0.682 (logrank test), Q value = 0.85
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 282 | 68 | 0.1 - 210.7 (22.6) |
subtype1 | 14 | 1 | 1.4 - 101.8 (26.4) |
subtype2 | 108 | 29 | 0.4 - 155.8 (20.7) |
subtype3 | 53 | 11 | 0.2 - 210.7 (23.0) |
subtype4 | 58 | 15 | 0.1 - 177.0 (22.8) |
subtype5 | 49 | 12 | 0.1 - 173.3 (25.0) |
P value = 0.00931 (Kruskal-Wallis (anova)), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 293 | 48.1 (13.8) |
subtype1 | 15 | 45.8 (12.3) |
subtype2 | 111 | 45.6 (14.0) |
subtype3 | 56 | 53.4 (12.4) |
subtype4 | 59 | 48.0 (12.8) |
subtype5 | 52 | 48.5 (15.2) |
P value = 0.0336 (Fisher's exact test), Q value = 0.2
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 135 | 70 | 21 | 8 |
subtype1 | 3 | 8 | 2 | 0 |
subtype2 | 50 | 25 | 6 | 2 |
subtype3 | 21 | 12 | 8 | 4 |
subtype4 | 32 | 17 | 2 | 1 |
subtype5 | 29 | 8 | 3 | 1 |
P value = 0.35 (Fisher's exact test), Q value = 0.66
nPatients | 0 | 1 |
---|---|---|
ALL | 129 | 56 |
subtype1 | 7 | 3 |
subtype2 | 42 | 22 |
subtype3 | 19 | 13 |
subtype4 | 34 | 9 |
subtype5 | 27 | 9 |
P value = 0.736 (Fisher's exact test), Q value = 0.87
nPatients | 0 | 1 |
---|---|---|
ALL | 108 | 10 |
subtype1 | 5 | 0 |
subtype2 | 42 | 4 |
subtype3 | 22 | 1 |
subtype4 | 22 | 4 |
subtype5 | 17 | 1 |
P value = 0.0136 (Fisher's exact test), Q value = 0.14
nPatients | NO | YES |
---|---|---|
ALL | 53 | 125 |
subtype1 | 1 | 8 |
subtype2 | 15 | 52 |
subtype3 | 8 | 31 |
subtype4 | 17 | 19 |
subtype5 | 12 | 15 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 6 | 242 | 6 | 21 | 3 | 17 |
subtype1 | 1 | 14 | 0 | 0 | 0 | 0 |
subtype2 | 3 | 96 | 2 | 3 | 1 | 7 |
subtype3 | 0 | 56 | 0 | 0 | 0 | 0 |
subtype4 | 2 | 31 | 4 | 13 | 2 | 7 |
subtype5 | 0 | 45 | 0 | 5 | 0 | 3 |
P value = 0.662 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 90 | 17.5 (14.3) |
subtype1 | 6 | 14.2 (10.2) |
subtype2 | 32 | 16.7 (12.2) |
subtype3 | 20 | 22.4 (17.9) |
subtype4 | 14 | 16.0 (10.8) |
subtype5 | 18 | 15.7 (16.6) |
P value = 0.048 (Kruskal-Wallis (anova)), Q value = 0.25
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 150 | 0.9 (2.1) |
subtype1 | 6 | 0.3 (0.8) |
subtype2 | 48 | 0.8 (1.3) |
subtype3 | 23 | 1.7 (2.3) |
subtype4 | 41 | 0.9 (2.8) |
subtype5 | 32 | 0.8 (1.8) |
P value = 0.239 (Fisher's exact test), Q value = 0.55
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 8 | 19 | 28 | 2 | 202 |
subtype1 | 1 | 0 | 0 | 0 | 13 |
subtype2 | 1 | 7 | 11 | 1 | 82 |
subtype3 | 0 | 4 | 9 | 0 | 29 |
subtype4 | 4 | 3 | 4 | 0 | 42 |
subtype5 | 2 | 5 | 4 | 1 | 36 |
P value = 0.225 (Fisher's exact test), Q value = 0.55
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 23 | 163 |
subtype1 | 2 | 9 |
subtype2 | 7 | 63 |
subtype3 | 2 | 28 |
subtype4 | 9 | 31 |
subtype5 | 3 | 32 |
P value = 0.324 (Kruskal-Wallis (anova)), Q value = 0.64
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 266 | 73.2 (21.6) |
subtype1 | 14 | 66.3 (15.6) |
subtype2 | 101 | 71.5 (18.3) |
subtype3 | 48 | 75.5 (29.4) |
subtype4 | 53 | 76.3 (16.9) |
subtype5 | 50 | 73.2 (24.6) |
P value = 0.949 (Fisher's exact test), Q value = 0.99
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 193 | 76 |
subtype1 | 11 | 3 |
subtype2 | 71 | 31 |
subtype3 | 34 | 14 |
subtype4 | 42 | 14 |
subtype5 | 35 | 14 |
P value = 0.0298 (Fisher's exact test), Q value = 0.2
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 18 | 129 | 115 | 1 | 24 |
subtype1 | 2 | 6 | 7 | 0 | 0 |
subtype2 | 2 | 40 | 56 | 1 | 9 |
subtype3 | 4 | 25 | 22 | 0 | 5 |
subtype4 | 8 | 30 | 16 | 0 | 5 |
subtype5 | 2 | 28 | 14 | 0 | 5 |
P value = 0.401 (Kruskal-Wallis (anova)), Q value = 0.7
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 43 | 1999.7 (13.6) |
subtype1 | 2 | 1991.0 (12.7) |
subtype2 | 18 | 2003.5 (10.6) |
subtype3 | 9 | 2000.2 (10.3) |
subtype4 | 7 | 2000.3 (14.4) |
subtype5 | 7 | 1991.1 (21.3) |
P value = 0.662 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 90 | 17.5 (14.3) |
subtype1 | 6 | 14.2 (10.2) |
subtype2 | 32 | 16.7 (12.2) |
subtype3 | 20 | 22.4 (17.9) |
subtype4 | 14 | 16.0 (10.8) |
subtype5 | 18 | 15.7 (16.6) |
P value = 0.338 (Kruskal-Wallis (anova)), Q value = 0.65
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 255 | 1.8 (1.1) |
subtype1 | 13 | 1.8 (1.1) |
subtype2 | 92 | 1.9 (1.2) |
subtype3 | 50 | 1.9 (1.1) |
subtype4 | 55 | 1.6 (1.0) |
subtype5 | 45 | 1.9 (1.1) |
P value = 0.527 (Kruskal-Wallis (anova)), Q value = 0.79
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 84 | 21.2 (7.7) |
subtype1 | 6 | 21.3 (3.3) |
subtype2 | 31 | 21.6 (9.4) |
subtype3 | 18 | 22.8 (8.0) |
subtype4 | 14 | 18.3 (5.2) |
subtype5 | 15 | 21.2 (6.5) |
P value = 1 (Fisher's exact test), Q value = 1
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 25 | 3 |
subtype1 | 1 | 0 |
subtype2 | 10 | 2 |
subtype3 | 4 | 1 |
subtype4 | 5 | 0 |
subtype5 | 5 | 0 |
P value = 0.669 (Kruskal-Wallis (anova)), Q value = 0.85
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 255 | 3.6 (2.5) |
subtype1 | 14 | 3.9 (2.7) |
subtype2 | 93 | 3.8 (2.9) |
subtype3 | 51 | 3.8 (2.5) |
subtype4 | 51 | 3.0 (1.9) |
subtype5 | 46 | 3.5 (2.3) |
P value = 0.0563 (Kruskal-Wallis (anova)), Q value = 0.28
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 106 | 0.1 (0.4) |
subtype1 | 6 | 0.0 (0.0) |
subtype2 | 35 | 0.0 (0.0) |
subtype3 | 19 | 0.3 (0.7) |
subtype4 | 25 | 0.1 (0.3) |
subtype5 | 21 | 0.0 (0.0) |
P value = 0.951 (Kruskal-Wallis (anova)), Q value = 0.99
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 140 | 0.6 (1.0) |
subtype1 | 8 | 0.4 (0.7) |
subtype2 | 47 | 0.5 (0.9) |
subtype3 | 28 | 0.6 (1.2) |
subtype4 | 30 | 0.6 (1.0) |
subtype5 | 27 | 0.5 (0.8) |
P value = 0.26 (Kruskal-Wallis (anova)), Q value = 0.57
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 251 | 2.8 (2.0) |
subtype1 | 14 | 3.4 (2.6) |
subtype2 | 96 | 3.0 (2.1) |
subtype3 | 47 | 3.1 (2.2) |
subtype4 | 47 | 2.3 (1.4) |
subtype5 | 47 | 2.5 (1.7) |
P value = 0.854 (Kruskal-Wallis (anova)), Q value = 0.93
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 0.8 (1.6) |
subtype1 | 6 | 0.3 (0.5) |
subtype2 | 39 | 1.0 (2.4) |
subtype3 | 20 | 0.7 (1.1) |
subtype4 | 28 | 0.7 (1.1) |
subtype5 | 23 | 0.9 (1.2) |
P value = 0.6 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 110 | 0.1 (0.4) |
subtype1 | 6 | 0.0 (0.0) |
subtype2 | 37 | 0.1 (0.3) |
subtype3 | 20 | 0.2 (0.5) |
subtype4 | 25 | 0.0 (0.2) |
subtype5 | 22 | 0.1 (0.4) |
P value = 0.177 (Fisher's exact test), Q value = 0.49
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 2 | 7 | 36 | 1 | 10 |
subtype1 | 1 | 0 | 1 | 0 | 0 |
subtype2 | 0 | 4 | 11 | 0 | 1 |
subtype3 | 0 | 1 | 8 | 0 | 3 |
subtype4 | 1 | 2 | 9 | 0 | 1 |
subtype5 | 0 | 0 | 7 | 1 | 5 |
P value = 0.241 (Fisher's exact test), Q value = 0.55
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 25 | 82 | 121 |
subtype1 | 0 | 0 | 3 | 10 |
subtype2 | 1 | 11 | 24 | 46 |
subtype3 | 0 | 4 | 25 | 17 |
subtype4 | 1 | 5 | 19 | 28 |
subtype5 | 1 | 5 | 11 | 20 |
P value = 0.172 (Fisher's exact test), Q value = 0.49
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 71 | 74 |
subtype1 | 2 | 3 |
subtype2 | 25 | 23 |
subtype3 | 12 | 15 |
subtype4 | 23 | 14 |
subtype5 | 9 | 19 |
P value = 0.048 (Kruskal-Wallis (anova)), Q value = 0.25
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 150 | 0.9 (2.1) |
subtype1 | 6 | 0.3 (0.8) |
subtype2 | 48 | 0.8 (1.3) |
subtype3 | 23 | 1.7 (2.3) |
subtype4 | 41 | 0.9 (2.8) |
subtype5 | 32 | 0.8 (1.8) |
P value = 0.742 (Kruskal-Wallis (anova)), Q value = 0.88
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 170 | 22.3 (12.8) |
subtype1 | 8 | 26.0 (13.0) |
subtype2 | 56 | 21.3 (12.4) |
subtype3 | 25 | 23.3 (15.1) |
subtype4 | 43 | 23.5 (12.9) |
subtype5 | 38 | 21.1 (11.9) |
P value = 0.524 (Fisher's exact test), Q value = 0.79
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 49 | 117 |
subtype1 | 5 | 6 |
subtype2 | 16 | 50 |
subtype3 | 12 | 21 |
subtype4 | 8 | 18 |
subtype5 | 8 | 22 |
P value = 0.63 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 293 | 2008.5 (4.6) |
subtype1 | 15 | 2009.7 (3.9) |
subtype2 | 111 | 2008.3 (4.6) |
subtype3 | 55 | 2009.1 (4.2) |
subtype4 | 59 | 2008.6 (4.8) |
subtype5 | 53 | 2007.9 (5.2) |
P value = 0.776 (Fisher's exact test), Q value = 0.89
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 15 | 54 | 85 |
subtype1 | 0 | 4 | 4 |
subtype2 | 5 | 18 | 33 |
subtype3 | 1 | 10 | 17 |
subtype4 | 6 | 12 | 20 |
subtype5 | 3 | 10 | 11 |
P value = 0.461 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 253 | 161.1 (6.9) |
subtype1 | 14 | 158.7 (10.6) |
subtype2 | 97 | 161.3 (6.7) |
subtype3 | 46 | 160.7 (6.2) |
subtype4 | 50 | 160.3 (6.4) |
subtype5 | 46 | 162.8 (7.3) |
P value = 0.95 (Fisher's exact test), Q value = 0.99
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 92 | 18 |
subtype1 | 3 | 1 |
subtype2 | 30 | 6 |
subtype3 | 15 | 2 |
subtype4 | 25 | 5 |
subtype5 | 19 | 4 |
P value = 0.259 (Fisher's exact test), Q value = 0.57
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 5 | 100 | 2 |
subtype1 | 0 | 8 | 0 |
subtype2 | 1 | 45 | 1 |
subtype3 | 1 | 21 | 0 |
subtype4 | 3 | 16 | 0 |
subtype5 | 0 | 10 | 1 |
P value = 0.768 (Kruskal-Wallis (anova)), Q value = 0.89
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 17 | 13.2 (7.2) |
subtype1 | 1 | 18.5 (NA) |
subtype2 | 7 | 13.9 (7.9) |
subtype3 | 4 | 12.1 (3.3) |
subtype4 | 3 | 15.6 (11.8) |
subtype5 | 2 | 6.8 (0.4) |
P value = 0.0112 (Kruskal-Wallis (anova)), Q value = 0.13
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 295 | 48.2 (13.8) |
subtype1 | 15 | 45.8 (12.3) |
subtype2 | 112 | 45.8 (14.0) |
subtype3 | 56 | 53.4 (12.4) |
subtype4 | 59 | 48.0 (12.8) |
subtype5 | 53 | 48.8 (15.1) |
P value = 0.0246 (Fisher's exact test), Q value = 0.2
nPatients | STAGE I | STAGE IA | STAGE IA1 | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 5 | 1 | 1 | 1 | 34 | 77 | 37 | 4 | 8 | 5 | 7 | 44 | 1 | 3 | 42 | 7 | 12 |
subtype1 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 0 | 0 | 5 | 0 | 1 | 2 | 0 | 0 |
subtype2 | 2 | 1 | 0 | 0 | 16 | 23 | 14 | 1 | 3 | 4 | 2 | 22 | 0 | 1 | 15 | 2 | 3 |
subtype3 | 1 | 0 | 0 | 1 | 3 | 14 | 3 | 0 | 1 | 0 | 1 | 7 | 1 | 1 | 15 | 4 | 2 |
subtype4 | 1 | 0 | 0 | 0 | 5 | 17 | 13 | 1 | 2 | 0 | 3 | 7 | 0 | 0 | 6 | 0 | 4 |
subtype5 | 1 | 0 | 1 | 0 | 9 | 21 | 5 | 2 | 0 | 1 | 1 | 3 | 0 | 0 | 4 | 1 | 3 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 72 | 122 | 113 |
P value = 0.967 (logrank test), Q value = 0.99
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 294 | 72 | 0.1 - 210.7 (23.2) |
subtype1 | 70 | 17 | 0.1 - 147.4 (20.6) |
subtype2 | 117 | 30 | 0.1 - 210.7 (20.9) |
subtype3 | 107 | 25 | 0.4 - 177.0 (24.8) |
P value = 0.174 (Kruskal-Wallis (anova)), Q value = 0.49
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 305 | 48.2 (13.8) |
subtype1 | 72 | 47.9 (12.1) |
subtype2 | 121 | 50.1 (14.5) |
subtype3 | 112 | 46.4 (13.9) |
P value = 0.422 (Fisher's exact test), Q value = 0.72
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 141 | 72 | 21 | 10 |
subtype1 | 39 | 18 | 4 | 1 |
subtype2 | 47 | 24 | 12 | 5 |
subtype3 | 55 | 30 | 5 | 4 |
P value = 0.232 (Fisher's exact test), Q value = 0.55
nPatients | 0 | 1 |
---|---|---|
ALL | 135 | 60 |
subtype1 | 36 | 13 |
subtype2 | 41 | 26 |
subtype3 | 58 | 21 |
P value = 0.36 (Fisher's exact test), Q value = 0.66
nPatients | 0 | 1 |
---|---|---|
ALL | 116 | 10 |
subtype1 | 24 | 4 |
subtype2 | 37 | 2 |
subtype3 | 55 | 4 |
P value = 0.773 (Fisher's exact test), Q value = 0.89
nPatients | NO | YES |
---|---|---|
ALL | 55 | 129 |
subtype1 | 16 | 31 |
subtype2 | 22 | 53 |
subtype3 | 17 | 45 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 6 | 254 | 6 | 21 | 3 | 17 |
subtype1 | 3 | 28 | 6 | 19 | 2 | 14 |
subtype2 | 0 | 122 | 0 | 0 | 0 | 0 |
subtype3 | 3 | 104 | 0 | 2 | 1 | 3 |
P value = 0.112 (Kruskal-Wallis (anova)), Q value = 0.4
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 19 | 16.4 (15.4) |
subtype2 | 43 | 20.9 (15.8) |
subtype3 | 31 | 13.0 (9.1) |
P value = 0.0366 (Kruskal-Wallis (anova)), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 42 | 1.0 (2.8) |
subtype2 | 54 | 1.4 (2.8) |
subtype3 | 63 | 0.7 (1.7) |
P value = 0.273 (Fisher's exact test), Q value = 0.59
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 8 | 20 | 30 | 2 | 211 |
subtype1 | 1 | 7 | 4 | 0 | 52 |
subtype2 | 4 | 4 | 11 | 2 | 85 |
subtype3 | 3 | 9 | 15 | 0 | 74 |
P value = 0.701 (Fisher's exact test), Q value = 0.86
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 24 | 171 |
subtype1 | 7 | 37 |
subtype2 | 9 | 68 |
subtype3 | 8 | 66 |
P value = 0.244 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 278 | 73.0 (21.5) |
subtype1 | 65 | 76.2 (22.7) |
subtype2 | 116 | 73.0 (20.1) |
subtype3 | 97 | 70.9 (22.4) |
P value = 0.561 (Fisher's exact test), Q value = 0.8
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 201 | 80 |
subtype1 | 46 | 21 |
subtype2 | 76 | 33 |
subtype3 | 79 | 26 |
P value = 0.375 (Fisher's exact test), Q value = 0.68
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 18 | 136 | 120 | 1 | 24 |
subtype1 | 7 | 27 | 31 | 0 | 6 |
subtype2 | 6 | 62 | 40 | 0 | 10 |
subtype3 | 5 | 47 | 49 | 1 | 8 |
P value = 0.497 (Kruskal-Wallis (anova)), Q value = 0.76
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 43 | 1999.7 (13.6) |
subtype1 | 9 | 1997.8 (11.8) |
subtype2 | 21 | 1998.3 (16.4) |
subtype3 | 13 | 2003.3 (9.5) |
P value = 0.112 (Kruskal-Wallis (anova)), Q value = 0.4
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 19 | 16.4 (15.4) |
subtype2 | 43 | 20.9 (15.8) |
subtype3 | 31 | 13.0 (9.1) |
P value = 0.0617 (Kruskal-Wallis (anova)), Q value = 0.29
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 263 | 1.8 (1.1) |
subtype1 | 64 | 1.6 (1.1) |
subtype2 | 99 | 2.0 (1.2) |
subtype3 | 100 | 1.8 (1.2) |
P value = 0.715 (Kruskal-Wallis (anova)), Q value = 0.86
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 85 | 21.1 (7.7) |
subtype1 | 17 | 21.4 (6.4) |
subtype2 | 39 | 21.4 (9.1) |
subtype3 | 29 | 20.6 (6.5) |
P value = 1 (Fisher's exact test), Q value = 1
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 29 | 3 |
subtype1 | 7 | 0 |
subtype2 | 8 | 1 |
subtype3 | 14 | 2 |
P value = 0.0168 (Kruskal-Wallis (anova)), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 267 | 3.6 (2.6) |
subtype1 | 64 | 3.0 (2.0) |
subtype2 | 103 | 4.2 (3.0) |
subtype3 | 100 | 3.4 (2.3) |
P value = 0.793 (Kruskal-Wallis (anova)), Q value = 0.9
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 112 | 0.1 (0.3) |
subtype1 | 26 | 0.0 (0.2) |
subtype2 | 44 | 0.0 (0.2) |
subtype3 | 42 | 0.1 (0.5) |
P value = 0.629 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 147 | 0.5 (0.9) |
subtype1 | 30 | 0.6 (0.9) |
subtype2 | 60 | 0.6 (1.2) |
subtype3 | 57 | 0.4 (0.6) |
P value = 0.0333 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 262 | 2.8 (2.0) |
subtype1 | 61 | 2.4 (1.9) |
subtype2 | 102 | 3.2 (2.2) |
subtype3 | 99 | 2.7 (1.9) |
P value = 0.76 (Kruskal-Wallis (anova)), Q value = 0.89
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 0.9 (1.8) |
subtype1 | 28 | 0.5 (0.7) |
subtype2 | 48 | 0.9 (2.2) |
subtype3 | 46 | 1.0 (1.8) |
P value = 0.291 (Kruskal-Wallis (anova)), Q value = 0.61
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 0.1 (0.3) |
subtype1 | 25 | 0.1 (0.3) |
subtype2 | 47 | 0.1 (0.2) |
subtype3 | 44 | 0.2 (0.4) |
P value = 0.366 (Fisher's exact test), Q value = 0.67
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 2 | 8 | 40 | 1 | 12 |
subtype1 | 2 | 2 | 10 | 0 | 2 |
subtype2 | 0 | 3 | 13 | 1 | 7 |
subtype3 | 0 | 3 | 17 | 0 | 3 |
P value = 0.0814 (Fisher's exact test), Q value = 0.33
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 25 | 84 | 125 |
subtype1 | 0 | 10 | 20 | 30 |
subtype2 | 2 | 10 | 37 | 39 |
subtype3 | 1 | 5 | 27 | 56 |
P value = 0.224 (Fisher's exact test), Q value = 0.55
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 72 | 80 |
subtype1 | 20 | 22 |
subtype2 | 20 | 32 |
subtype3 | 32 | 26 |
P value = 0.0366 (Kruskal-Wallis (anova)), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 42 | 1.0 (2.8) |
subtype2 | 54 | 1.4 (2.8) |
subtype3 | 63 | 0.7 (1.7) |
P value = 0.804 (Kruskal-Wallis (anova)), Q value = 0.91
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 180 | 22.3 (12.6) |
subtype1 | 46 | 22.2 (10.2) |
subtype2 | 62 | 22.8 (14.1) |
subtype3 | 72 | 21.9 (12.7) |
P value = 0.0271 (Fisher's exact test), Q value = 0.2
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 55 | 120 |
subtype1 | 1 | 17 |
subtype2 | 31 | 55 |
subtype3 | 23 | 48 |
P value = 0.947 (Kruskal-Wallis (anova)), Q value = 0.99
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 305 | 2008.3 (4.8) |
subtype1 | 71 | 2008.7 (4.1) |
subtype2 | 121 | 2008.2 (4.9) |
subtype3 | 113 | 2008.2 (5.0) |
P value = 0.235 (Fisher's exact test), Q value = 0.55
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 15 | 54 | 90 |
subtype1 | 7 | 17 | 19 |
subtype2 | 3 | 20 | 37 |
subtype3 | 5 | 17 | 34 |
P value = 0.573 (Kruskal-Wallis (anova)), Q value = 0.81
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 264 | 161.0 (7.3) |
subtype1 | 62 | 161.4 (7.1) |
subtype2 | 110 | 161.4 (7.0) |
subtype3 | 92 | 160.1 (7.8) |
P value = 0.17 (Fisher's exact test), Q value = 0.49
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 99 | 19 |
subtype1 | 33 | 4 |
subtype2 | 32 | 4 |
subtype3 | 34 | 11 |
P value = 0.628 (Fisher's exact test), Q value = 0.84
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 7 | 104 | 2 |
subtype1 | 2 | 20 | 1 |
subtype2 | 3 | 40 | 0 |
subtype3 | 2 | 44 | 1 |
P value = 0.385 (Kruskal-Wallis (anova)), Q value = 0.68
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 17 | 13.2 (7.2) |
subtype1 | 2 | 10.8 (5.2) |
subtype2 | 7 | 15.3 (7.2) |
subtype3 | 8 | 12.0 (7.9) |
P value = 0.184 (Kruskal-Wallis (anova)), Q value = 0.5
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 307 | 48.3 (13.8) |
subtype1 | 72 | 47.9 (12.1) |
subtype2 | 122 | 50.1 (14.5) |
subtype3 | 113 | 46.5 (13.9) |
P value = 0.0591 (Fisher's exact test), Q value = 0.29
nPatients | STAGE I | STAGE IA | STAGE IA1 | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 5 | 1 | 1 | 1 | 38 | 78 | 39 | 5 | 9 | 5 | 7 | 44 | 1 | 3 | 42 | 9 | 12 |
subtype1 | 1 | 0 | 0 | 0 | 5 | 28 | 12 | 1 | 3 | 1 | 0 | 9 | 0 | 0 | 8 | 0 | 4 |
subtype2 | 4 | 0 | 1 | 1 | 12 | 23 | 13 | 3 | 2 | 0 | 4 | 17 | 1 | 2 | 22 | 6 | 5 |
subtype3 | 0 | 1 | 0 | 0 | 21 | 27 | 14 | 1 | 4 | 4 | 3 | 18 | 0 | 1 | 12 | 3 | 3 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 60 | 45 | 68 |
P value = 0.0599 (logrank test), Q value = 0.29
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 164 | 31 | 0.1 - 210.7 (22.8) |
subtype1 | 57 | 14 | 0.1 - 144.2 (18.0) |
subtype2 | 41 | 6 | 0.4 - 173.3 (27.2) |
subtype3 | 66 | 11 | 0.1 - 210.7 (24.3) |
P value = 0.0786 (Kruskal-Wallis (anova)), Q value = 0.32
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 171 | 47.5 (13.5) |
subtype1 | 60 | 44.4 (12.5) |
subtype2 | 44 | 49.4 (14.0) |
subtype3 | 67 | 49.1 (13.8) |
P value = 0.891 (Fisher's exact test), Q value = 0.96
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 99 | 32 | 7 | 3 |
subtype1 | 34 | 10 | 1 | 1 |
subtype2 | 26 | 7 | 3 | 1 |
subtype3 | 39 | 15 | 3 | 1 |
P value = 0.661 (Fisher's exact test), Q value = 0.84
nPatients | 0 | 1 |
---|---|---|
ALL | 93 | 38 |
subtype1 | 33 | 11 |
subtype2 | 22 | 8 |
subtype3 | 38 | 19 |
P value = 0.55 (Fisher's exact test), Q value = 0.79
nPatients | 0 | 1 |
---|---|---|
ALL | 84 | 4 |
subtype1 | 28 | 2 |
subtype2 | 25 | 0 |
subtype3 | 31 | 2 |
P value = 0.611 (Fisher's exact test), Q value = 0.84
nPatients | NO | YES |
---|---|---|
ALL | 26 | 60 |
subtype1 | 7 | 22 |
subtype2 | 7 | 17 |
subtype3 | 12 | 21 |
P value = 0.311 (Fisher's exact test), Q value = 0.63
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 4 | 144 | 3 | 16 | 2 | 4 |
subtype1 | 3 | 51 | 1 | 3 | 0 | 2 |
subtype2 | 0 | 41 | 0 | 3 | 0 | 1 |
subtype3 | 1 | 52 | 2 | 10 | 2 | 1 |
P value = 0.198 (Kruskal-Wallis (anova)), Q value = 0.51
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 45 | 17.7 (13.7) |
subtype1 | 12 | 12.8 (8.3) |
subtype2 | 12 | 14.2 (11.0) |
subtype3 | 21 | 22.5 (16.1) |
P value = 0.632 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 105 | 1.1 (2.7) |
subtype1 | 33 | 0.9 (2.3) |
subtype2 | 23 | 1.2 (2.1) |
subtype3 | 49 | 1.3 (3.2) |
P value = 0.307 (Fisher's exact test), Q value = 0.63
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 3 | 15 | 12 | 1 | 125 |
subtype1 | 1 | 4 | 7 | 1 | 42 |
subtype2 | 1 | 7 | 1 | 0 | 32 |
subtype3 | 1 | 4 | 4 | 0 | 51 |
P value = 0.432 (Fisher's exact test), Q value = 0.72
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 13 | 113 |
subtype1 | 3 | 43 |
subtype2 | 5 | 27 |
subtype3 | 5 | 43 |
P value = 0.0556 (Kruskal-Wallis (anova)), Q value = 0.28
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 158 | 74.7 (23.1) |
subtype1 | 52 | 68.7 (17.3) |
subtype2 | 42 | 75.1 (17.5) |
subtype3 | 64 | 79.2 (29.0) |
P value = 0.674 (Fisher's exact test), Q value = 0.85
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 119 | 36 |
subtype1 | 40 | 14 |
subtype2 | 32 | 7 |
subtype3 | 47 | 15 |
P value = 0.34 (Fisher's exact test), Q value = 0.65
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 10 | 75 | 74 | 1 | 8 |
subtype1 | 3 | 26 | 25 | 1 | 4 |
subtype2 | 2 | 23 | 14 | 0 | 3 |
subtype3 | 5 | 26 | 35 | 0 | 1 |
P value = 0.838 (Kruskal-Wallis (anova)), Q value = 0.93
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 31 | 2001.5 (10.7) |
subtype1 | 9 | 2003.9 (7.6) |
subtype2 | 9 | 2001.0 (10.4) |
subtype3 | 13 | 2000.3 (13.1) |
P value = 0.198 (Kruskal-Wallis (anova)), Q value = 0.51
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 45 | 17.7 (13.7) |
subtype1 | 12 | 12.8 (8.3) |
subtype2 | 12 | 14.2 (11.0) |
subtype3 | 21 | 22.5 (16.1) |
P value = 0.802 (Kruskal-Wallis (anova)), Q value = 0.91
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 145 | 1.9 (1.2) |
subtype1 | 49 | 1.9 (1.3) |
subtype2 | 40 | 1.9 (1.3) |
subtype3 | 56 | 1.9 (1.2) |
P value = 0.747 (Kruskal-Wallis (anova)), Q value = 0.88
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 44 | 21.5 (7.9) |
subtype1 | 11 | 21.9 (8.2) |
subtype2 | 11 | 20.8 (8.1) |
subtype3 | 22 | 21.7 (8.0) |
P value = 0.725 (Fisher's exact test), Q value = 0.87
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 21 | 2 |
subtype1 | 9 | 1 |
subtype2 | 5 | 1 |
subtype3 | 7 | 0 |
P value = 0.472 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 151 | 3.6 (2.6) |
subtype1 | 48 | 3.4 (2.3) |
subtype2 | 44 | 4.3 (3.4) |
subtype3 | 59 | 3.3 (2.0) |
P value = 0.458 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 72 | 0.0 (0.2) |
subtype1 | 26 | 0.1 (0.3) |
subtype2 | 17 | 0.0 (0.0) |
subtype3 | 29 | 0.0 (0.2) |
P value = 0.806 (Kruskal-Wallis (anova)), Q value = 0.91
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 89 | 0.4 (0.8) |
subtype1 | 29 | 0.3 (0.5) |
subtype2 | 24 | 0.5 (1.1) |
subtype3 | 36 | 0.5 (0.8) |
P value = 0.124 (Kruskal-Wallis (anova)), Q value = 0.41
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 151 | 2.6 (1.9) |
subtype1 | 50 | 2.4 (2.1) |
subtype2 | 43 | 3.2 (2.2) |
subtype3 | 58 | 2.4 (1.3) |
P value = 0.786 (Kruskal-Wallis (anova)), Q value = 0.9
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 81 | 1.1 (2.2) |
subtype1 | 30 | 0.9 (1.3) |
subtype2 | 19 | 1.8 (3.6) |
subtype3 | 32 | 0.9 (1.6) |
P value = 0.919 (Kruskal-Wallis (anova)), Q value = 0.98
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 0.1 (0.4) |
subtype1 | 26 | 0.1 (0.3) |
subtype2 | 18 | 0.1 (0.3) |
subtype3 | 30 | 0.1 (0.4) |
P value = 0.366 (Fisher's exact test), Q value = 0.67
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 2 | 7 | 25 | 1 | 7 |
subtype1 | 2 | 1 | 5 | 1 | 2 |
subtype2 | 0 | 1 | 7 | 0 | 1 |
subtype3 | 0 | 5 | 13 | 0 | 4 |
P value = 0.128 (Fisher's exact test), Q value = 0.42
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 13 | 46 | 79 |
subtype1 | 0 | 2 | 13 | 35 |
subtype2 | 1 | 6 | 12 | 17 |
subtype3 | 2 | 5 | 21 | 27 |
P value = 0.0301 (Fisher's exact test), Q value = 0.2
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 52 | 60 |
subtype1 | 22 | 15 |
subtype2 | 15 | 13 |
subtype3 | 15 | 32 |
P value = 0.632 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 105 | 1.1 (2.7) |
subtype1 | 33 | 0.9 (2.3) |
subtype2 | 23 | 1.2 (2.1) |
subtype3 | 49 | 1.3 (3.2) |
P value = 0.00935 (Kruskal-Wallis (anova)), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 20.8 (11.9) |
subtype1 | 41 | 20.7 (11.3) |
subtype2 | 25 | 14.8 (8.1) |
subtype3 | 56 | 23.5 (12.8) |
P value = 0.0795 (Fisher's exact test), Q value = 0.32
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 39 | 76 |
subtype1 | 15 | 29 |
subtype2 | 6 | 25 |
subtype3 | 18 | 22 |
P value = 0.524 (Kruskal-Wallis (anova)), Q value = 0.79
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 171 | 2008.3 (5.0) |
subtype1 | 59 | 2008.5 (5.1) |
subtype2 | 45 | 2008.5 (4.7) |
subtype3 | 67 | 2007.8 (5.1) |
P value = 0.697 (Fisher's exact test), Q value = 0.86
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 5 | 32 | 51 |
subtype1 | 2 | 10 | 16 |
subtype2 | 0 | 8 | 16 |
subtype3 | 3 | 14 | 19 |
P value = 0.126 (Kruskal-Wallis (anova)), Q value = 0.41
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 153 | 161.7 (7.1) |
subtype1 | 51 | 162.4 (6.6) |
subtype2 | 43 | 160.2 (8.0) |
subtype3 | 59 | 162.1 (6.8) |
P value = 0.127 (Fisher's exact test), Q value = 0.41
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 84 | 12 |
subtype1 | 27 | 3 |
subtype2 | 26 | 1 |
subtype3 | 31 | 8 |
P value = 0.509 (Fisher's exact test), Q value = 0.77
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 3 | 48 | 1 |
subtype1 | 0 | 18 | 1 |
subtype2 | 1 | 15 | 0 |
subtype3 | 2 | 15 | 0 |
P value = 0.0662 (Kruskal-Wallis (anova)), Q value = 0.29
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 11 | 13.2 (8.7) |
subtype1 | 4 | 16.1 (7.3) |
subtype2 | 2 | 23.6 (7.3) |
subtype3 | 5 | 6.6 (4.4) |
P value = 0.0597 (Kruskal-Wallis (anova)), Q value = 0.29
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 173 | 47.7 (13.5) |
subtype1 | 60 | 44.4 (12.5) |
subtype2 | 45 | 49.7 (14.0) |
subtype3 | 68 | 49.2 (13.7) |
P value = 0.645 (Fisher's exact test), Q value = 0.84
nPatients | STAGE I | STAGE IA | STAGE IA1 | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 4 | 1 | 1 | 1 | 27 | 48 | 28 | 4 | 5 | 4 | 4 | 16 | 1 | 1 | 19 | 4 | 2 |
subtype1 | 1 | 1 | 1 | 0 | 8 | 15 | 13 | 0 | 2 | 1 | 1 | 8 | 0 | 0 | 6 | 1 | 1 |
subtype2 | 2 | 0 | 0 | 1 | 8 | 12 | 4 | 3 | 1 | 0 | 0 | 4 | 0 | 1 | 7 | 2 | 0 |
subtype3 | 1 | 0 | 0 | 0 | 11 | 21 | 11 | 1 | 2 | 3 | 3 | 4 | 1 | 0 | 6 | 1 | 1 |
Cluster Labels | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Number of samples | 32 | 49 | 51 | 23 | 18 |
P value = 0.183 (logrank test), Q value = 0.5
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 164 | 31 | 0.1 - 210.7 (22.8) |
subtype1 | 31 | 6 | 0.4 - 144.2 (18.0) |
subtype2 | 48 | 7 | 0.1 - 210.7 (22.6) |
subtype3 | 48 | 8 | 0.4 - 209.6 (26.7) |
subtype4 | 21 | 7 | 0.9 - 78.7 (24.6) |
subtype5 | 16 | 3 | 0.1 - 147.4 (25.1) |
P value = 0.0879 (Kruskal-Wallis (anova)), Q value = 0.35
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 171 | 47.5 (13.5) |
subtype1 | 31 | 44.2 (14.4) |
subtype2 | 48 | 47.5 (13.5) |
subtype3 | 51 | 48.9 (13.4) |
subtype4 | 23 | 44.2 (12.3) |
subtype5 | 18 | 53.8 (12.1) |
P value = 0.645 (Fisher's exact test), Q value = 0.84
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 99 | 32 | 7 | 3 |
subtype1 | 19 | 4 | 0 | 0 |
subtype2 | 31 | 9 | 2 | 0 |
subtype3 | 24 | 11 | 4 | 2 |
subtype4 | 13 | 3 | 1 | 1 |
subtype5 | 12 | 5 | 0 | 0 |
P value = 0.213 (Fisher's exact test), Q value = 0.54
nPatients | 0 | 1 |
---|---|---|
ALL | 93 | 38 |
subtype1 | 17 | 4 |
subtype2 | 30 | 12 |
subtype3 | 19 | 14 |
subtype4 | 13 | 6 |
subtype5 | 14 | 2 |
P value = 1 (Fisher's exact test), Q value = 1
nPatients | 0 | 1 |
---|---|---|
ALL | 84 | 4 |
subtype1 | 12 | 1 |
subtype2 | 24 | 1 |
subtype3 | 26 | 1 |
subtype4 | 12 | 1 |
subtype5 | 10 | 0 |
P value = 0.303 (Fisher's exact test), Q value = 0.62
nPatients | NO | YES |
---|---|---|
ALL | 26 | 60 |
subtype1 | 7 | 10 |
subtype2 | 9 | 16 |
subtype3 | 5 | 25 |
subtype4 | 3 | 6 |
subtype5 | 2 | 3 |
P value = 0.00394 (Fisher's exact test), Q value = 0.073
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 4 | 144 | 3 | 16 | 2 | 4 |
subtype1 | 2 | 26 | 1 | 2 | 0 | 1 |
subtype2 | 2 | 35 | 1 | 8 | 2 | 1 |
subtype3 | 0 | 49 | 0 | 1 | 0 | 1 |
subtype4 | 0 | 23 | 0 | 0 | 0 | 0 |
subtype5 | 0 | 11 | 1 | 5 | 0 | 1 |
P value = 0.54 (Kruskal-Wallis (anova)), Q value = 0.79
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 45 | 17.7 (13.7) |
subtype1 | 8 | 10.9 (7.4) |
subtype2 | 15 | 17.3 (10.7) |
subtype3 | 14 | 20.8 (16.6) |
subtype4 | 6 | 20.6 (20.0) |
subtype5 | 2 | 18.0 (11.3) |
P value = 0.177 (Kruskal-Wallis (anova)), Q value = 0.49
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 105 | 1.1 (2.7) |
subtype1 | 16 | 1.3 (2.9) |
subtype2 | 39 | 1.3 (3.5) |
subtype3 | 25 | 1.2 (1.6) |
subtype4 | 14 | 0.6 (1.6) |
subtype5 | 11 | 0.7 (2.4) |
P value = 0.209 (Fisher's exact test), Q value = 0.54
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 3 | 15 | 12 | 1 | 125 |
subtype1 | 0 | 4 | 3 | 1 | 23 |
subtype2 | 2 | 1 | 2 | 0 | 37 |
subtype3 | 1 | 4 | 3 | 0 | 37 |
subtype4 | 0 | 2 | 4 | 0 | 15 |
subtype5 | 0 | 4 | 0 | 0 | 13 |
P value = 0.473 (Fisher's exact test), Q value = 0.74
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 13 | 113 |
subtype1 | 1 | 28 |
subtype2 | 3 | 29 |
subtype3 | 6 | 29 |
subtype4 | 1 | 14 |
subtype5 | 2 | 13 |
P value = 0.542 (Kruskal-Wallis (anova)), Q value = 0.79
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 158 | 74.7 (23.1) |
subtype1 | 27 | 68.4 (19.0) |
subtype2 | 45 | 76.0 (20.0) |
subtype3 | 48 | 76.6 (27.3) |
subtype4 | 20 | 72.6 (12.8) |
subtype5 | 18 | 77.8 (31.8) |
P value = 0.53 (Fisher's exact test), Q value = 0.79
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 119 | 36 |
subtype1 | 24 | 6 |
subtype2 | 36 | 9 |
subtype3 | 36 | 9 |
subtype4 | 13 | 7 |
subtype5 | 10 | 5 |
P value = 0.551 (Fisher's exact test), Q value = 0.79
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 10 | 75 | 74 | 1 | 8 |
subtype1 | 2 | 15 | 12 | 0 | 3 |
subtype2 | 5 | 16 | 26 | 0 | 2 |
subtype3 | 2 | 26 | 17 | 0 | 2 |
subtype4 | 1 | 9 | 10 | 1 | 1 |
subtype5 | 0 | 9 | 9 | 0 | 0 |
P value = 0.706 (Kruskal-Wallis (anova)), Q value = 0.86
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 31 | 2001.5 (10.7) |
subtype1 | 6 | 2002.2 (8.0) |
subtype2 | 11 | 2000.3 (14.3) |
subtype3 | 10 | 2004.3 (8.2) |
subtype4 | 1 | 2000.0 (NA) |
subtype5 | 3 | 1996.3 (11.8) |
P value = 0.54 (Kruskal-Wallis (anova)), Q value = 0.79
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 45 | 17.7 (13.7) |
subtype1 | 8 | 10.9 (7.4) |
subtype2 | 15 | 17.3 (10.7) |
subtype3 | 14 | 20.8 (16.6) |
subtype4 | 6 | 20.6 (20.0) |
subtype5 | 2 | 18.0 (11.3) |
P value = 0.471 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 145 | 1.9 (1.2) |
subtype1 | 27 | 1.6 (1.0) |
subtype2 | 39 | 2.0 (1.3) |
subtype3 | 44 | 2.0 (1.3) |
subtype4 | 19 | 1.8 (1.2) |
subtype5 | 16 | 1.6 (1.1) |
P value = 0.808 (Kruskal-Wallis (anova)), Q value = 0.91
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 44 | 21.5 (7.9) |
subtype1 | 7 | 23.4 (9.6) |
subtype2 | 14 | 20.9 (7.1) |
subtype3 | 15 | 20.5 (7.9) |
subtype4 | 5 | 21.4 (5.9) |
subtype5 | 3 | 25.3 (13.6) |
P value = 1 (Fisher's exact test), Q value = 1
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 21 | 2 |
subtype1 | 5 | 1 |
subtype2 | 6 | 0 |
subtype3 | 7 | 1 |
subtype4 | 3 | 0 |
subtype5 | 0 | 0 |
P value = 0.622 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 151 | 3.6 (2.6) |
subtype1 | 25 | 3.3 (2.1) |
subtype2 | 41 | 3.3 (1.7) |
subtype3 | 49 | 3.9 (2.9) |
subtype4 | 21 | 3.3 (2.9) |
subtype5 | 15 | 4.8 (3.6) |
P value = 0.224 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 72 | 0.0 (0.2) |
subtype1 | 13 | 0.2 (0.4) |
subtype2 | 21 | 0.0 (0.2) |
subtype3 | 22 | 0.0 (0.0) |
subtype4 | 11 | 0.0 (0.0) |
subtype5 | 5 | 0.0 (0.0) |
P value = 0.809 (Kruskal-Wallis (anova)), Q value = 0.91
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 89 | 0.4 (0.8) |
subtype1 | 15 | 0.3 (0.6) |
subtype2 | 25 | 0.4 (0.9) |
subtype3 | 28 | 0.6 (1.1) |
subtype4 | 14 | 0.4 (0.5) |
subtype5 | 7 | 0.4 (0.5) |
P value = 0.114 (Kruskal-Wallis (anova)), Q value = 0.4
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 151 | 2.6 (1.9) |
subtype1 | 26 | 2.3 (1.7) |
subtype2 | 40 | 2.4 (1.4) |
subtype3 | 48 | 2.9 (1.8) |
subtype4 | 21 | 2.4 (2.6) |
subtype5 | 16 | 3.3 (2.3) |
P value = 0.655 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 81 | 1.1 (2.2) |
subtype1 | 16 | 1.1 (1.5) |
subtype2 | 23 | 0.7 (1.2) |
subtype3 | 23 | 1.2 (2.5) |
subtype4 | 12 | 0.9 (1.2) |
subtype5 | 7 | 2.6 (4.7) |
P value = 0.638 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 74 | 0.1 (0.4) |
subtype1 | 12 | 0.0 (0.0) |
subtype2 | 23 | 0.1 (0.3) |
subtype3 | 22 | 0.1 (0.5) |
subtype4 | 12 | 0.2 (0.4) |
subtype5 | 5 | 0.2 (0.4) |
P value = 0.251 (Fisher's exact test), Q value = 0.56
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 2 | 7 | 25 | 1 | 7 |
subtype1 | 2 | 1 | 3 | 0 | 0 |
subtype2 | 0 | 4 | 10 | 0 | 3 |
subtype3 | 0 | 2 | 7 | 0 | 2 |
subtype4 | 0 | 0 | 3 | 1 | 2 |
subtype5 | 0 | 0 | 2 | 0 | 0 |
P value = 0.873 (Fisher's exact test), Q value = 0.95
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 13 | 46 | 79 |
subtype1 | 0 | 2 | 7 | 19 |
subtype2 | 1 | 3 | 15 | 23 |
subtype3 | 2 | 6 | 13 | 18 |
subtype4 | 0 | 1 | 5 | 12 |
subtype5 | 0 | 1 | 6 | 7 |
P value = 0.425 (Fisher's exact test), Q value = 0.72
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 52 | 60 |
subtype1 | 13 | 8 |
subtype2 | 13 | 22 |
subtype3 | 12 | 17 |
subtype4 | 6 | 6 |
subtype5 | 8 | 7 |
P value = 0.177 (Kruskal-Wallis (anova)), Q value = 0.49
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 105 | 1.1 (2.7) |
subtype1 | 16 | 1.3 (2.9) |
subtype2 | 39 | 1.3 (3.5) |
subtype3 | 25 | 1.2 (1.6) |
subtype4 | 14 | 0.6 (1.6) |
subtype5 | 11 | 0.7 (2.4) |
P value = 0.236 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 20.8 (11.9) |
subtype1 | 22 | 18.4 (9.4) |
subtype2 | 45 | 24.2 (12.6) |
subtype3 | 26 | 19.3 (10.9) |
subtype4 | 16 | 19.6 (14.9) |
subtype5 | 13 | 17.3 (8.9) |
P value = 0.0376 (Fisher's exact test), Q value = 0.21
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 39 | 76 |
subtype1 | 7 | 18 |
subtype2 | 16 | 14 |
subtype3 | 10 | 25 |
subtype4 | 6 | 11 |
subtype5 | 0 | 8 |
P value = 0.841 (Kruskal-Wallis (anova)), Q value = 0.93
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 171 | 2008.3 (5.0) |
subtype1 | 32 | 2008.3 (5.5) |
subtype2 | 47 | 2008.6 (4.4) |
subtype3 | 51 | 2008.1 (5.2) |
subtype4 | 23 | 2007.1 (5.6) |
subtype5 | 18 | 2009.2 (3.8) |
P value = 0.552 (Fisher's exact test), Q value = 0.79
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 5 | 32 | 51 |
subtype1 | 0 | 4 | 8 |
subtype2 | 3 | 12 | 13 |
subtype3 | 1 | 6 | 18 |
subtype4 | 0 | 6 | 8 |
subtype5 | 1 | 4 | 4 |
P value = 0.167 (Kruskal-Wallis (anova)), Q value = 0.49
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 153 | 161.7 (7.1) |
subtype1 | 26 | 162.4 (6.5) |
subtype2 | 43 | 162.3 (5.7) |
subtype3 | 46 | 160.1 (8.7) |
subtype4 | 20 | 164.4 (6.1) |
subtype5 | 18 | 160.3 (7.2) |
P value = 0.455 (Fisher's exact test), Q value = 0.74
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 84 | 12 |
subtype1 | 16 | 1 |
subtype2 | 24 | 3 |
subtype3 | 25 | 3 |
subtype4 | 9 | 1 |
subtype5 | 10 | 4 |
P value = 0.00359 (Fisher's exact test), Q value = 0.073
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 3 | 48 | 1 |
subtype1 | 0 | 9 | 1 |
subtype2 | 1 | 10 | 0 |
subtype3 | 0 | 22 | 0 |
subtype4 | 0 | 6 | 0 |
subtype5 | 2 | 1 | 0 |
P value = 0.117 (Kruskal-Wallis (anova)), Q value = 0.4
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 173 | 47.7 (13.5) |
subtype1 | 32 | 44.8 (14.5) |
subtype2 | 49 | 47.7 (13.5) |
subtype3 | 51 | 48.9 (13.4) |
subtype4 | 23 | 44.2 (12.3) |
subtype5 | 18 | 53.8 (12.1) |
P value = 0.13 (Fisher's exact test), Q value = 0.42
nPatients | STAGE I | STAGE IA | STAGE IA1 | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 4 | 1 | 1 | 1 | 27 | 48 | 28 | 4 | 5 | 4 | 4 | 16 | 1 | 1 | 19 | 4 | 2 |
subtype1 | 1 | 1 | 1 | 0 | 4 | 7 | 9 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 3 | 0 | 1 |
subtype2 | 1 | 0 | 0 | 0 | 8 | 20 | 8 | 0 | 1 | 1 | 2 | 3 | 0 | 0 | 3 | 0 | 1 |
subtype3 | 1 | 0 | 0 | 1 | 8 | 10 | 4 | 2 | 1 | 0 | 0 | 8 | 1 | 1 | 10 | 3 | 0 |
subtype4 | 1 | 0 | 0 | 0 | 5 | 5 | 3 | 0 | 1 | 1 | 1 | 2 | 0 | 0 | 3 | 1 | 0 |
subtype5 | 0 | 0 | 0 | 0 | 2 | 6 | 4 | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Cluster Labels | 1 | 2 | 3 | 4 |
---|---|---|---|---|
Number of samples | 61 | 103 | 69 | 71 |
P value = 0.44 (logrank test), Q value = 0.72
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 291 | 72 | 0.1 - 210.7 (23.5) |
subtype1 | 58 | 12 | 0.1 - 146.9 (21.8) |
subtype2 | 98 | 24 | 0.2 - 210.7 (26.7) |
subtype3 | 68 | 15 | 0.4 - 147.4 (25.0) |
subtype4 | 67 | 21 | 0.1 - 154.3 (18.7) |
P value = 8.51e-06 (Kruskal-Wallis (anova)), Q value = 0.00043
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 302 | 48.2 (13.9) |
subtype1 | 61 | 53.2 (12.6) |
subtype2 | 102 | 50.7 (14.9) |
subtype3 | 69 | 46.2 (12.1) |
subtype4 | 70 | 41.9 (12.4) |
P value = 0.661 (Fisher's exact test), Q value = 0.84
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 140 | 71 | 20 | 10 |
subtype1 | 24 | 17 | 5 | 3 |
subtype2 | 47 | 25 | 8 | 4 |
subtype3 | 40 | 14 | 2 | 1 |
subtype4 | 29 | 15 | 5 | 2 |
P value = 0.377 (Fisher's exact test), Q value = 0.68
nPatients | 0 | 1 |
---|---|---|
ALL | 133 | 60 |
subtype1 | 26 | 13 |
subtype2 | 44 | 26 |
subtype3 | 35 | 10 |
subtype4 | 28 | 11 |
P value = 0.267 (Fisher's exact test), Q value = 0.58
nPatients | 0 | 1 |
---|---|---|
ALL | 116 | 10 |
subtype1 | 25 | 4 |
subtype2 | 43 | 1 |
subtype3 | 23 | 2 |
subtype4 | 25 | 3 |
P value = 0.888 (Fisher's exact test), Q value = 0.96
nPatients | NO | YES |
---|---|---|
ALL | 55 | 127 |
subtype1 | 9 | 26 |
subtype2 | 16 | 39 |
subtype3 | 15 | 30 |
subtype4 | 15 | 32 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 5 | 252 | 6 | 21 | 3 | 17 |
subtype1 | 3 | 50 | 2 | 3 | 1 | 2 |
subtype2 | 0 | 103 | 0 | 0 | 0 | 0 |
subtype3 | 2 | 28 | 4 | 18 | 2 | 15 |
subtype4 | 0 | 71 | 0 | 0 | 0 | 0 |
P value = 0.106 (Kruskal-Wallis (anova)), Q value = 0.39
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 19 | 22.4 (17.0) |
subtype2 | 37 | 19.7 (15.0) |
subtype3 | 17 | 12.3 (10.6) |
subtype4 | 20 | 12.6 (9.4) |
P value = 0.0146 (Kruskal-Wallis (anova)), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 32 | 1.2 (2.9) |
subtype2 | 57 | 1.5 (2.3) |
subtype3 | 44 | 0.8 (2.7) |
subtype4 | 26 | 0.3 (0.6) |
P value = 0.00901 (Fisher's exact test), Q value = 0.11
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 7 | 20 | 30 | 2 | 209 |
subtype1 | 2 | 7 | 9 | 0 | 38 |
subtype2 | 1 | 7 | 10 | 0 | 69 |
subtype3 | 0 | 2 | 1 | 0 | 55 |
subtype4 | 4 | 4 | 10 | 2 | 47 |
P value = 0.255 (Fisher's exact test), Q value = 0.57
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 24 | 169 |
subtype1 | 2 | 39 |
subtype2 | 8 | 59 |
subtype3 | 5 | 32 |
subtype4 | 9 | 39 |
P value = 0.694 (Kruskal-Wallis (anova)), Q value = 0.86
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 275 | 72.9 (21.5) |
subtype1 | 55 | 72.3 (24.8) |
subtype2 | 93 | 73.3 (25.0) |
subtype3 | 63 | 73.3 (15.8) |
subtype4 | 64 | 72.4 (18.1) |
P value = 0.38 (Fisher's exact test), Q value = 0.68
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 198 | 80 |
subtype1 | 36 | 21 |
subtype2 | 69 | 22 |
subtype3 | 48 | 17 |
subtype4 | 45 | 20 |
P value = 0.00049 (Fisher's exact test), Q value = 0.014
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 18 | 135 | 118 | 1 | 24 |
subtype1 | 2 | 22 | 32 | 1 | 2 |
subtype2 | 7 | 62 | 26 | 0 | 6 |
subtype3 | 7 | 30 | 25 | 0 | 7 |
subtype4 | 2 | 21 | 35 | 0 | 9 |
P value = 0.836 (Kruskal-Wallis (anova)), Q value = 0.93
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 43 | 1999.7 (13.6) |
subtype1 | 8 | 1999.2 (11.7) |
subtype2 | 17 | 1997.5 (16.6) |
subtype3 | 11 | 2001.5 (12.6) |
subtype4 | 7 | 2002.6 (10.6) |
P value = 0.106 (Kruskal-Wallis (anova)), Q value = 0.39
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 19 | 22.4 (17.0) |
subtype2 | 37 | 19.7 (15.0) |
subtype3 | 17 | 12.3 (10.6) |
subtype4 | 20 | 12.6 (9.4) |
P value = 0.255 (Kruskal-Wallis (anova)), Q value = 0.57
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 261 | 1.8 (1.1) |
subtype1 | 50 | 2.0 (1.2) |
subtype2 | 92 | 1.9 (1.2) |
subtype3 | 60 | 1.7 (1.2) |
subtype4 | 59 | 1.7 (1.1) |
P value = 0.226 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 85 | 21.1 (7.7) |
subtype1 | 17 | 23.3 (7.5) |
subtype2 | 36 | 21.4 (8.3) |
subtype3 | 15 | 19.9 (4.4) |
subtype4 | 17 | 19.4 (8.7) |
P value = 0.733 (Fisher's exact test), Q value = 0.87
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 29 | 3 |
subtype1 | 7 | 0 |
subtype2 | 10 | 1 |
subtype3 | 4 | 0 |
subtype4 | 8 | 2 |
P value = 0.0261 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 264 | 3.6 (2.6) |
subtype1 | 51 | 3.4 (2.4) |
subtype2 | 91 | 4.1 (2.7) |
subtype3 | 61 | 3.0 (2.1) |
subtype4 | 61 | 3.7 (2.8) |
P value = 0.164 (Kruskal-Wallis (anova)), Q value = 0.49
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 112 | 0.1 (0.3) |
subtype1 | 19 | 0.0 (0.0) |
subtype2 | 46 | 0.2 (0.5) |
subtype3 | 26 | 0.0 (0.2) |
subtype4 | 21 | 0.0 (0.0) |
P value = 0.772 (Kruskal-Wallis (anova)), Q value = 0.89
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 147 | 0.5 (0.9) |
subtype1 | 25 | 0.5 (1.1) |
subtype2 | 62 | 0.5 (1.0) |
subtype3 | 28 | 0.5 (0.8) |
subtype4 | 32 | 0.6 (0.9) |
P value = 0.0381 (Kruskal-Wallis (anova)), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 260 | 2.9 (2.1) |
subtype1 | 52 | 2.6 (1.7) |
subtype2 | 89 | 3.1 (1.9) |
subtype3 | 59 | 2.4 (2.1) |
subtype4 | 60 | 3.1 (2.4) |
P value = 0.815 (Kruskal-Wallis (anova)), Q value = 0.91
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 0.9 (1.8) |
subtype1 | 21 | 0.8 (1.4) |
subtype2 | 51 | 1.2 (2.5) |
subtype3 | 27 | 0.6 (0.8) |
subtype4 | 23 | 0.5 (0.9) |
P value = 0.192 (Kruskal-Wallis (anova)), Q value = 0.51
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 0.1 (0.3) |
subtype1 | 20 | 0.2 (0.4) |
subtype2 | 49 | 0.1 (0.4) |
subtype3 | 26 | 0.1 (0.3) |
subtype4 | 21 | 0.0 (0.0) |
P value = 0.359 (Fisher's exact test), Q value = 0.66
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 2 | 8 | 40 | 1 | 12 |
subtype1 | 1 | 1 | 5 | 0 | 4 |
subtype2 | 0 | 2 | 16 | 1 | 5 |
subtype3 | 1 | 2 | 10 | 0 | 3 |
subtype4 | 0 | 3 | 9 | 0 | 0 |
P value = 0.0481 (Fisher's exact test), Q value = 0.25
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 25 | 82 | 124 |
subtype1 | 0 | 6 | 22 | 23 |
subtype2 | 2 | 8 | 34 | 37 |
subtype3 | 1 | 7 | 19 | 30 |
subtype4 | 0 | 4 | 7 | 34 |
P value = 0.819 (Fisher's exact test), Q value = 0.92
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 71 | 79 |
subtype1 | 15 | 19 |
subtype2 | 25 | 29 |
subtype3 | 18 | 21 |
subtype4 | 13 | 10 |
P value = 0.0146 (Kruskal-Wallis (anova)), Q value = 0.15
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 32 | 1.2 (2.9) |
subtype2 | 57 | 1.5 (2.3) |
subtype3 | 44 | 0.8 (2.7) |
subtype4 | 26 | 0.3 (0.6) |
P value = 0.174 (Kruskal-Wallis (anova)), Q value = 0.49
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 178 | 22.4 (12.6) |
subtype1 | 37 | 19.5 (12.6) |
subtype2 | 60 | 23.0 (14.4) |
subtype3 | 49 | 24.0 (11.1) |
subtype4 | 32 | 22.0 (10.9) |
P value = 0.0321 (Fisher's exact test), Q value = 0.2
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 55 | 119 |
subtype1 | 15 | 22 |
subtype2 | 21 | 53 |
subtype3 | 1 | 16 |
subtype4 | 18 | 28 |
P value = 0.347 (Kruskal-Wallis (anova)), Q value = 0.66
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 302 | 2008.3 (4.8) |
subtype1 | 61 | 2009.1 (4.0) |
subtype2 | 102 | 2008.0 (5.4) |
subtype3 | 68 | 2008.7 (4.1) |
subtype4 | 71 | 2007.6 (4.9) |
P value = 0.0953 (Fisher's exact test), Q value = 0.36
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 15 | 53 | 89 |
subtype1 | 0 | 13 | 20 |
subtype2 | 3 | 15 | 31 |
subtype3 | 8 | 15 | 18 |
subtype4 | 4 | 10 | 20 |
P value = 0.291 (Kruskal-Wallis (anova)), Q value = 0.61
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 261 | 161.0 (7.1) |
subtype1 | 52 | 159.7 (6.7) |
subtype2 | 88 | 160.5 (7.3) |
subtype3 | 61 | 162.2 (7.3) |
subtype4 | 60 | 161.7 (6.9) |
P value = 0.0691 (Fisher's exact test), Q value = 0.3
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 99 | 19 |
subtype1 | 19 | 6 |
subtype2 | 32 | 9 |
subtype3 | 28 | 4 |
subtype4 | 20 | 0 |
P value = 0.396 (Fisher's exact test), Q value = 0.7
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 7 | 102 | 2 |
subtype1 | 3 | 16 | 0 |
subtype2 | 2 | 34 | 0 |
subtype3 | 1 | 20 | 1 |
subtype4 | 1 | 32 | 1 |
P value = 0.231 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 17 | 13.2 (7.2) |
subtype1 | 3 | 13.4 (1.3) |
subtype2 | 9 | 11.7 (8.4) |
subtype3 | 1 | 7.1 (NA) |
subtype4 | 4 | 18.0 (6.0) |
P value = 1.34e-05 (Kruskal-Wallis (anova)), Q value = 0.00052
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 304 | 48.2 (13.8) |
subtype1 | 61 | 53.2 (12.6) |
subtype2 | 103 | 50.8 (14.9) |
subtype3 | 69 | 46.2 (12.1) |
subtype4 | 71 | 42.2 (12.5) |
P value = 0.0304 (Fisher's exact test), Q value = 0.2
nPatients | STAGE I | STAGE IA | STAGE IA1 | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 5 | 1 | 1 | 1 | 38 | 77 | 39 | 5 | 9 | 5 | 7 | 43 | 1 | 2 | 42 | 9 | 12 |
subtype1 | 1 | 1 | 1 | 0 | 5 | 13 | 9 | 1 | 1 | 3 | 4 | 7 | 0 | 1 | 8 | 2 | 3 |
subtype2 | 1 | 0 | 0 | 1 | 15 | 22 | 9 | 4 | 2 | 1 | 2 | 12 | 1 | 0 | 20 | 4 | 5 |
subtype3 | 1 | 0 | 0 | 0 | 5 | 31 | 10 | 0 | 2 | 0 | 0 | 10 | 0 | 0 | 5 | 1 | 3 |
subtype4 | 2 | 0 | 0 | 0 | 13 | 11 | 11 | 0 | 4 | 1 | 1 | 14 | 0 | 1 | 9 | 2 | 1 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 72 | 195 | 37 |
P value = 0.0302 (logrank test), Q value = 0.2
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 291 | 72 | 0.1 - 210.7 (23.5) |
subtype1 | 70 | 17 | 0.5 - 137.2 (20.6) |
subtype2 | 185 | 42 | 0.1 - 210.7 (24.6) |
subtype3 | 36 | 13 | 0.4 - 99.9 (17.2) |
P value = 0.00802 (Kruskal-Wallis (anova)), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 302 | 48.2 (13.9) |
subtype1 | 72 | 47.6 (11.6) |
subtype2 | 193 | 49.7 (14.5) |
subtype3 | 37 | 41.4 (12.7) |
P value = 0.704 (Fisher's exact test), Q value = 0.86
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 140 | 71 | 20 | 10 |
subtype1 | 39 | 20 | 3 | 2 |
subtype2 | 86 | 42 | 16 | 8 |
subtype3 | 15 | 9 | 1 | 0 |
P value = 0.349 (Fisher's exact test), Q value = 0.66
nPatients | 0 | 1 |
---|---|---|
ALL | 133 | 60 |
subtype1 | 38 | 13 |
subtype2 | 78 | 42 |
subtype3 | 17 | 5 |
P value = 0.0524 (Fisher's exact test), Q value = 0.27
nPatients | 0 | 1 |
---|---|---|
ALL | 116 | 10 |
subtype1 | 27 | 5 |
subtype2 | 77 | 3 |
subtype3 | 12 | 2 |
P value = 1 (Fisher's exact test), Q value = 1
nPatients | NO | YES |
---|---|---|
ALL | 55 | 127 |
subtype1 | 14 | 33 |
subtype2 | 35 | 79 |
subtype3 | 6 | 15 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 5 | 252 | 6 | 21 | 3 | 17 |
subtype1 | 5 | 22 | 5 | 21 | 3 | 16 |
subtype2 | 0 | 193 | 1 | 0 | 0 | 1 |
subtype3 | 0 | 37 | 0 | 0 | 0 | 0 |
P value = 0.437 (Kruskal-Wallis (anova)), Q value = 0.72
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 18 | 14.2 (12.0) |
subtype2 | 63 | 19.0 (15.2) |
subtype3 | 12 | 13.8 (9.9) |
P value = 0.0308 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 44 | 0.7 (2.2) |
subtype2 | 97 | 1.4 (2.6) |
subtype3 | 18 | 0.2 (0.5) |
P value = 0.307 (Fisher's exact test), Q value = 0.63
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 7 | 20 | 30 | 2 | 209 |
subtype1 | 1 | 6 | 3 | 0 | 53 |
subtype2 | 4 | 13 | 20 | 2 | 130 |
subtype3 | 2 | 1 | 7 | 0 | 26 |
P value = 0.896 (Fisher's exact test), Q value = 0.96
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 24 | 169 |
subtype1 | 6 | 38 |
subtype2 | 16 | 109 |
subtype3 | 2 | 22 |
P value = 0.677 (Kruskal-Wallis (anova)), Q value = 0.85
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 275 | 72.9 (21.5) |
subtype1 | 66 | 72.5 (17.0) |
subtype2 | 177 | 72.9 (23.6) |
subtype3 | 32 | 73.6 (17.6) |
P value = 0.425 (Fisher's exact test), Q value = 0.72
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 198 | 80 |
subtype1 | 45 | 22 |
subtype2 | 130 | 46 |
subtype3 | 23 | 12 |
P value = 0.157 (Fisher's exact test), Q value = 0.47
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 18 | 135 | 118 | 1 | 24 |
subtype1 | 7 | 30 | 29 | 0 | 6 |
subtype2 | 10 | 93 | 69 | 0 | 16 |
subtype3 | 1 | 12 | 20 | 1 | 2 |
P value = 0.569 (Kruskal-Wallis (anova)), Q value = 0.81
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 43 | 1999.7 (13.6) |
subtype1 | 9 | 2002.1 (12.6) |
subtype2 | 30 | 1999.1 (14.8) |
subtype3 | 4 | 1999.0 (5.2) |
P value = 0.437 (Kruskal-Wallis (anova)), Q value = 0.72
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 18 | 14.2 (12.0) |
subtype2 | 63 | 19.0 (15.2) |
subtype3 | 12 | 13.8 (9.9) |
P value = 0.0944 (Kruskal-Wallis (anova)), Q value = 0.36
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 261 | 1.8 (1.1) |
subtype1 | 65 | 1.6 (1.1) |
subtype2 | 166 | 1.9 (1.2) |
subtype3 | 30 | 1.9 (1.2) |
P value = 0.655 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 85 | 21.1 (7.7) |
subtype1 | 17 | 20.8 (5.7) |
subtype2 | 56 | 21.5 (8.1) |
subtype3 | 12 | 19.8 (8.3) |
P value = 1 (Fisher's exact test), Q value = 1
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 29 | 3 |
subtype1 | 3 | 0 |
subtype2 | 20 | 2 |
subtype3 | 6 | 1 |
P value = 0.0475 (Kruskal-Wallis (anova)), Q value = 0.25
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 264 | 3.6 (2.6) |
subtype1 | 65 | 3.0 (2.0) |
subtype2 | 167 | 3.8 (2.7) |
subtype3 | 32 | 4.0 (2.8) |
P value = 0.574 (Kruskal-Wallis (anova)), Q value = 0.81
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 112 | 0.1 (0.3) |
subtype1 | 25 | 0.0 (0.2) |
subtype2 | 74 | 0.1 (0.4) |
subtype3 | 13 | 0.0 (0.0) |
P value = 0.13 (Kruskal-Wallis (anova)), Q value = 0.42
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 147 | 0.5 (0.9) |
subtype1 | 29 | 0.6 (0.9) |
subtype2 | 98 | 0.5 (0.9) |
subtype3 | 20 | 0.8 (1.1) |
P value = 0.0188 (Kruskal-Wallis (anova)), Q value = 0.17
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 260 | 2.9 (2.1) |
subtype1 | 63 | 2.3 (1.8) |
subtype2 | 165 | 3.0 (2.0) |
subtype3 | 32 | 3.2 (2.4) |
P value = 0.616 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 0.9 (1.8) |
subtype1 | 27 | 0.7 (1.0) |
subtype2 | 80 | 0.9 (2.1) |
subtype3 | 15 | 0.6 (1.0) |
P value = 0.855 (Kruskal-Wallis (anova)), Q value = 0.93
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 0.1 (0.3) |
subtype1 | 24 | 0.1 (0.3) |
subtype2 | 79 | 0.1 (0.4) |
subtype3 | 13 | 0.1 (0.3) |
P value = 0.426 (Fisher's exact test), Q value = 0.72
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 2 | 8 | 40 | 1 | 12 |
subtype1 | 2 | 1 | 9 | 0 | 2 |
subtype2 | 0 | 5 | 26 | 1 | 9 |
subtype3 | 0 | 2 | 5 | 0 | 1 |
P value = 0.0234 (Fisher's exact test), Q value = 0.2
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 25 | 82 | 124 |
subtype1 | 0 | 8 | 19 | 34 |
subtype2 | 2 | 15 | 61 | 72 |
subtype3 | 1 | 2 | 2 | 18 |
P value = 0.639 (Fisher's exact test), Q value = 0.84
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 71 | 79 |
subtype1 | 23 | 21 |
subtype2 | 39 | 50 |
subtype3 | 9 | 8 |
P value = 0.0308 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 44 | 0.7 (2.2) |
subtype2 | 97 | 1.4 (2.6) |
subtype3 | 18 | 0.2 (0.5) |
P value = 0.342 (Kruskal-Wallis (anova)), Q value = 0.65
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 178 | 22.4 (12.6) |
subtype1 | 48 | 21.2 (10.2) |
subtype2 | 109 | 22.2 (13.4) |
subtype3 | 21 | 25.7 (13.0) |
P value = 0.00374 (Fisher's exact test), Q value = 0.073
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 55 | 119 |
subtype1 | 0 | 17 |
subtype2 | 47 | 89 |
subtype3 | 8 | 13 |
P value = 0.0135 (Kruskal-Wallis (anova)), Q value = 0.14
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 302 | 2008.3 (4.8) |
subtype1 | 71 | 2009.5 (3.5) |
subtype2 | 194 | 2008.2 (4.8) |
subtype3 | 37 | 2006.4 (5.8) |
P value = 0.0336 (Fisher's exact test), Q value = 0.2
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 15 | 53 | 89 |
subtype1 | 7 | 17 | 21 |
subtype2 | 4 | 32 | 59 |
subtype3 | 4 | 4 | 9 |
P value = 0.146 (Kruskal-Wallis (anova)), Q value = 0.46
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 261 | 161.0 (7.1) |
subtype1 | 64 | 161.1 (6.9) |
subtype2 | 167 | 160.5 (7.2) |
subtype3 | 30 | 163.5 (6.8) |
P value = 0.342 (Fisher's exact test), Q value = 0.65
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 99 | 19 |
subtype1 | 31 | 6 |
subtype2 | 56 | 13 |
subtype3 | 12 | 0 |
P value = 0.117 (Fisher's exact test), Q value = 0.4
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 7 | 102 | 2 |
subtype1 | 3 | 22 | 1 |
subtype2 | 4 | 67 | 0 |
subtype3 | 0 | 13 | 1 |
P value = 0.226 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 17 | 13.2 (7.2) |
subtype1 | 1 | 7.1 (NA) |
subtype2 | 13 | 12.5 (7.0) |
subtype3 | 3 | 18.4 (7.3) |
P value = 0.00655 (Kruskal-Wallis (anova)), Q value = 0.1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 304 | 48.2 (13.8) |
subtype1 | 72 | 47.6 (11.6) |
subtype2 | 195 | 49.8 (14.4) |
subtype3 | 37 | 41.4 (12.7) |
P value = 0.106 (Fisher's exact test), Q value = 0.39
nPatients | STAGE I | STAGE IA | STAGE IA1 | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 5 | 1 | 1 | 1 | 38 | 77 | 39 | 5 | 9 | 5 | 7 | 43 | 1 | 2 | 42 | 9 | 12 |
subtype1 | 1 | 0 | 0 | 0 | 6 | 28 | 10 | 1 | 3 | 1 | 2 | 8 | 0 | 0 | 6 | 1 | 5 |
subtype2 | 4 | 1 | 1 | 1 | 24 | 44 | 20 | 4 | 3 | 2 | 4 | 30 | 1 | 2 | 33 | 8 | 7 |
subtype3 | 0 | 0 | 0 | 0 | 8 | 5 | 9 | 0 | 3 | 2 | 1 | 5 | 0 | 0 | 3 | 0 | 0 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 108 | 78 | 121 |
P value = 0.889 (logrank test), Q value = 0.96
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 294 | 72 | 0.1 - 210.7 (23.2) |
subtype1 | 106 | 25 | 0.2 - 210.7 (21.8) |
subtype2 | 75 | 17 | 0.1 - 155.8 (21.7) |
subtype3 | 113 | 30 | 0.1 - 209.6 (24.0) |
P value = 0.619 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 305 | 48.2 (13.8) |
subtype1 | 108 | 48.1 (11.9) |
subtype2 | 78 | 49.1 (13.7) |
subtype3 | 119 | 47.7 (15.5) |
P value = 0.172 (Fisher's exact test), Q value = 0.49
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 141 | 72 | 21 | 10 |
subtype1 | 53 | 28 | 10 | 6 |
subtype2 | 46 | 14 | 3 | 1 |
subtype3 | 42 | 30 | 8 | 3 |
P value = 0.609 (Fisher's exact test), Q value = 0.84
nPatients | 0 | 1 |
---|---|---|
ALL | 135 | 60 |
subtype1 | 48 | 18 |
subtype2 | 40 | 22 |
subtype3 | 47 | 20 |
P value = 0.0987 (Fisher's exact test), Q value = 0.37
nPatients | 0 | 1 |
---|---|---|
ALL | 116 | 10 |
subtype1 | 39 | 7 |
subtype2 | 36 | 1 |
subtype3 | 41 | 2 |
P value = 0.955 (Fisher's exact test), Q value = 0.99
nPatients | NO | YES |
---|---|---|
ALL | 55 | 129 |
subtype1 | 23 | 54 |
subtype2 | 13 | 28 |
subtype3 | 19 | 47 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 6 | 254 | 6 | 21 | 3 | 17 |
subtype1 | 5 | 66 | 5 | 17 | 3 | 12 |
subtype2 | 1 | 68 | 1 | 4 | 0 | 4 |
subtype3 | 0 | 120 | 0 | 0 | 0 | 1 |
P value = 0.0659 (Kruskal-Wallis (anova)), Q value = 0.29
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 28 | 14.2 (13.1) |
subtype2 | 25 | 22.5 (14.9) |
subtype3 | 40 | 16.4 (13.8) |
P value = 0.242 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 55 | 0.8 (2.2) |
subtype2 | 55 | 1.4 (2.5) |
subtype3 | 49 | 0.9 (2.5) |
P value = 0.217 (Fisher's exact test), Q value = 0.55
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 8 | 20 | 30 | 2 | 211 |
subtype1 | 1 | 8 | 10 | 0 | 73 |
subtype2 | 1 | 8 | 6 | 0 | 54 |
subtype3 | 6 | 4 | 14 | 2 | 84 |
P value = 0.674 (Fisher's exact test), Q value = 0.85
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 24 | 171 |
subtype1 | 7 | 57 |
subtype2 | 5 | 46 |
subtype3 | 12 | 68 |
P value = 0.551 (Kruskal-Wallis (anova)), Q value = 0.79
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 278 | 73.0 (21.5) |
subtype1 | 102 | 73.7 (20.1) |
subtype2 | 68 | 72.6 (27.4) |
subtype3 | 108 | 72.6 (18.7) |
P value = 0.58 (Fisher's exact test), Q value = 0.81
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 201 | 80 |
subtype1 | 69 | 31 |
subtype2 | 54 | 17 |
subtype3 | 78 | 32 |
P value = 0.00417 (Fisher's exact test), Q value = 0.074
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 18 | 136 | 120 | 1 | 24 |
subtype1 | 8 | 42 | 43 | 0 | 14 |
subtype2 | 8 | 41 | 27 | 1 | 1 |
subtype3 | 2 | 53 | 50 | 0 | 9 |
P value = 0.125 (Kruskal-Wallis (anova)), Q value = 0.41
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 43 | 1999.7 (13.6) |
subtype1 | 12 | 2002.9 (11.5) |
subtype2 | 10 | 1994.6 (11.2) |
subtype3 | 21 | 2000.3 (15.5) |
P value = 0.0659 (Kruskal-Wallis (anova)), Q value = 0.29
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 28 | 14.2 (13.1) |
subtype2 | 25 | 22.5 (14.9) |
subtype3 | 40 | 16.4 (13.8) |
P value = 0.043 (Kruskal-Wallis (anova)), Q value = 0.23
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 263 | 1.8 (1.1) |
subtype1 | 97 | 1.6 (1.0) |
subtype2 | 68 | 1.9 (1.2) |
subtype3 | 98 | 1.9 (1.2) |
P value = 0.892 (Kruskal-Wallis (anova)), Q value = 0.96
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 85 | 21.1 (7.7) |
subtype1 | 25 | 20.8 (6.7) |
subtype2 | 22 | 20.7 (5.8) |
subtype3 | 38 | 21.6 (9.2) |
P value = 0.551 (Fisher's exact test), Q value = 0.79
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 29 | 3 |
subtype1 | 7 | 0 |
subtype2 | 6 | 0 |
subtype3 | 16 | 3 |
P value = 0.506 (Kruskal-Wallis (anova)), Q value = 0.77
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 267 | 3.6 (2.6) |
subtype1 | 97 | 3.5 (2.9) |
subtype2 | 70 | 3.6 (2.3) |
subtype3 | 100 | 3.6 (2.5) |
P value = 0.756 (Kruskal-Wallis (anova)), Q value = 0.89
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 112 | 0.1 (0.3) |
subtype1 | 31 | 0.1 (0.2) |
subtype2 | 35 | 0.1 (0.5) |
subtype3 | 46 | 0.1 (0.2) |
P value = 0.0206 (Kruskal-Wallis (anova)), Q value = 0.19
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 147 | 0.5 (0.9) |
subtype1 | 43 | 0.8 (1.2) |
subtype2 | 45 | 0.4 (0.8) |
subtype3 | 59 | 0.4 (0.8) |
P value = 0.649 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 262 | 2.8 (2.0) |
subtype1 | 92 | 2.9 (2.5) |
subtype2 | 69 | 2.7 (1.7) |
subtype3 | 101 | 2.9 (1.9) |
P value = 0.462 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 0.9 (1.8) |
subtype1 | 34 | 0.8 (1.4) |
subtype2 | 39 | 1.1 (2.3) |
subtype3 | 49 | 0.7 (1.7) |
P value = 0.338 (Kruskal-Wallis (anova)), Q value = 0.65
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 0.1 (0.3) |
subtype1 | 31 | 0.1 (0.2) |
subtype2 | 37 | 0.2 (0.5) |
subtype3 | 48 | 0.1 (0.3) |
P value = 0.0901 (Fisher's exact test), Q value = 0.35
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 2 | 8 | 40 | 1 | 12 |
subtype1 | 2 | 1 | 10 | 0 | 2 |
subtype2 | 0 | 1 | 16 | 1 | 7 |
subtype3 | 0 | 6 | 14 | 0 | 3 |
P value = 0.727 (Fisher's exact test), Q value = 0.87
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 25 | 84 | 125 |
subtype1 | 1 | 12 | 26 | 48 |
subtype2 | 1 | 6 | 26 | 30 |
subtype3 | 1 | 7 | 32 | 47 |
P value = 0.607 (Fisher's exact test), Q value = 0.84
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 72 | 80 |
subtype1 | 25 | 29 |
subtype2 | 22 | 29 |
subtype3 | 25 | 22 |
P value = 0.242 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 55 | 0.8 (2.2) |
subtype2 | 55 | 1.4 (2.5) |
subtype3 | 49 | 0.9 (2.5) |
P value = 0.847 (Kruskal-Wallis (anova)), Q value = 0.93
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 180 | 22.3 (12.6) |
subtype1 | 60 | 21.1 (11.6) |
subtype2 | 61 | 23.6 (14.1) |
subtype3 | 59 | 22.1 (11.8) |
P value = 0.0335 (Fisher's exact test), Q value = 0.2
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 55 | 120 |
subtype1 | 6 | 34 |
subtype2 | 18 | 32 |
subtype3 | 31 | 54 |
P value = 0.000899 (Kruskal-Wallis (anova)), Q value = 0.022
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 305 | 2008.3 (4.8) |
subtype1 | 107 | 2009.4 (4.5) |
subtype2 | 77 | 2008.1 (4.7) |
subtype3 | 121 | 2007.6 (4.9) |
P value = 0.731 (Fisher's exact test), Q value = 0.87
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 15 | 54 | 90 |
subtype1 | 8 | 22 | 36 |
subtype2 | 3 | 15 | 19 |
subtype3 | 4 | 17 | 35 |
P value = 0.904 (Kruskal-Wallis (anova)), Q value = 0.96
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 264 | 161.0 (7.3) |
subtype1 | 97 | 160.9 (7.0) |
subtype2 | 63 | 161.0 (8.0) |
subtype3 | 104 | 161.0 (7.2) |
P value = 0.577 (Fisher's exact test), Q value = 0.81
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 99 | 19 |
subtype1 | 35 | 7 |
subtype2 | 32 | 8 |
subtype3 | 32 | 4 |
P value = 0.841 (Fisher's exact test), Q value = 0.93
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 7 | 104 | 2 |
subtype1 | 3 | 39 | 0 |
subtype2 | 1 | 20 | 0 |
subtype3 | 3 | 45 | 2 |
P value = 0.367 (Kruskal-Wallis (anova)), Q value = 0.67
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 17 | 13.2 (7.2) |
subtype1 | 3 | 16.8 (11.0) |
subtype2 | 6 | 9.5 (5.7) |
subtype3 | 8 | 14.7 (6.3) |
P value = 0.698 (Kruskal-Wallis (anova)), Q value = 0.86
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 307 | 48.3 (13.8) |
subtype1 | 108 | 48.1 (11.9) |
subtype2 | 78 | 49.1 (13.7) |
subtype3 | 121 | 47.9 (15.4) |
P value = 0.00923 (Fisher's exact test), Q value = 0.11
nPatients | STAGE I | STAGE IA | STAGE IA1 | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 5 | 1 | 1 | 1 | 38 | 78 | 39 | 5 | 9 | 5 | 7 | 44 | 1 | 3 | 42 | 9 | 12 |
subtype1 | 3 | 0 | 0 | 0 | 10 | 30 | 17 | 1 | 2 | 1 | 5 | 11 | 0 | 2 | 13 | 4 | 9 |
subtype2 | 0 | 1 | 1 | 1 | 8 | 28 | 11 | 1 | 3 | 2 | 1 | 6 | 0 | 0 | 10 | 2 | 1 |
subtype3 | 2 | 0 | 0 | 0 | 20 | 20 | 11 | 3 | 4 | 2 | 1 | 27 | 1 | 1 | 19 | 3 | 2 |
Cluster Labels | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Number of samples | 60 | 102 | 74 | 26 | 45 |
P value = 0.692 (logrank test), Q value = 0.86
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 294 | 72 | 0.1 - 210.7 (23.2) |
subtype1 | 59 | 15 | 0.5 - 137.2 (18.8) |
subtype2 | 97 | 21 | 0.1 - 160.4 (20.9) |
subtype3 | 70 | 17 | 0.1 - 210.7 (31.3) |
subtype4 | 24 | 7 | 0.3 - 209.6 (25.1) |
subtype5 | 44 | 12 | 0.1 - 144.2 (17.9) |
P value = 0.000125 (Kruskal-Wallis (anova)), Q value = 0.0038
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 305 | 48.2 (13.8) |
subtype1 | 60 | 46.5 (12.5) |
subtype2 | 101 | 50.4 (14.3) |
subtype3 | 74 | 51.2 (14.1) |
subtype4 | 25 | 49.9 (11.3) |
subtype5 | 45 | 39.7 (11.6) |
P value = 0.00365 (Fisher's exact test), Q value = 0.073
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 141 | 72 | 21 | 10 |
subtype1 | 35 | 13 | 2 | 1 |
subtype2 | 32 | 29 | 12 | 6 |
subtype3 | 47 | 11 | 2 | 1 |
subtype4 | 8 | 9 | 2 | 1 |
subtype5 | 19 | 10 | 3 | 1 |
P value = 0.23 (Fisher's exact test), Q value = 0.55
nPatients | 0 | 1 |
---|---|---|
ALL | 135 | 60 |
subtype1 | 32 | 10 |
subtype2 | 33 | 22 |
subtype3 | 38 | 20 |
subtype4 | 11 | 2 |
subtype5 | 21 | 6 |
P value = 0.354 (Fisher's exact test), Q value = 0.66
nPatients | 0 | 1 |
---|---|---|
ALL | 116 | 10 |
subtype1 | 18 | 2 |
subtype2 | 29 | 2 |
subtype3 | 38 | 1 |
subtype4 | 12 | 2 |
subtype5 | 19 | 3 |
P value = 0.445 (Fisher's exact test), Q value = 0.73
nPatients | NO | YES |
---|---|---|
ALL | 55 | 129 |
subtype1 | 11 | 28 |
subtype2 | 17 | 51 |
subtype3 | 14 | 19 |
subtype4 | 6 | 11 |
subtype5 | 7 | 20 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 6 | 254 | 6 | 21 | 3 | 17 |
subtype1 | 5 | 13 | 4 | 19 | 3 | 16 |
subtype2 | 1 | 99 | 1 | 1 | 0 | 0 |
subtype3 | 0 | 74 | 0 | 0 | 0 | 0 |
subtype4 | 0 | 24 | 1 | 0 | 0 | 1 |
subtype5 | 0 | 44 | 0 | 1 | 0 | 0 |
P value = 0.157 (Kruskal-Wallis (anova)), Q value = 0.47
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 18 | 14.7 (11.6) |
subtype2 | 36 | 19.9 (17.8) |
subtype3 | 21 | 20.2 (10.9) |
subtype4 | 5 | 7.7 (8.3) |
subtype5 | 13 | 13.4 (9.5) |
P value = 0.134 (Kruskal-Wallis (anova)), Q value = 0.42
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 40 | 0.6 (1.9) |
subtype2 | 40 | 1.7 (3.1) |
subtype3 | 50 | 1.0 (1.9) |
subtype4 | 8 | 0.4 (0.7) |
subtype5 | 21 | 0.9 (3.1) |
P value = 0.33 (Fisher's exact test), Q value = 0.65
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 8 | 20 | 30 | 2 | 211 |
subtype1 | 0 | 5 | 2 | 0 | 45 |
subtype2 | 3 | 5 | 13 | 0 | 66 |
subtype3 | 1 | 6 | 7 | 0 | 51 |
subtype4 | 1 | 2 | 3 | 1 | 17 |
subtype5 | 3 | 2 | 5 | 1 | 32 |
P value = 0.412 (Fisher's exact test), Q value = 0.71
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 24 | 171 |
subtype1 | 4 | 31 |
subtype2 | 10 | 53 |
subtype3 | 3 | 50 |
subtype4 | 3 | 16 |
subtype5 | 4 | 21 |
P value = 0.933 (Kruskal-Wallis (anova)), Q value = 0.98
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 278 | 73.0 (21.5) |
subtype1 | 54 | 71.7 (16.8) |
subtype2 | 96 | 72.8 (20.3) |
subtype3 | 65 | 75.2 (28.7) |
subtype4 | 24 | 68.6 (17.0) |
subtype5 | 39 | 74.6 (19.2) |
P value = 0.713 (Fisher's exact test), Q value = 0.86
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 201 | 80 |
subtype1 | 40 | 17 |
subtype2 | 67 | 26 |
subtype3 | 51 | 16 |
subtype4 | 14 | 9 |
subtype5 | 29 | 12 |
P value = 0.0228 (Fisher's exact test), Q value = 0.2
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 18 | 136 | 120 | 1 | 24 |
subtype1 | 6 | 27 | 21 | 0 | 6 |
subtype2 | 4 | 46 | 38 | 0 | 8 |
subtype3 | 6 | 39 | 28 | 0 | 1 |
subtype4 | 0 | 14 | 9 | 0 | 3 |
subtype5 | 2 | 10 | 24 | 1 | 6 |
P value = 0.147 (Kruskal-Wallis (anova)), Q value = 0.46
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 43 | 1999.7 (13.6) |
subtype1 | 9 | 2002.1 (12.6) |
subtype2 | 16 | 2001.1 (17.6) |
subtype3 | 8 | 1992.9 (10.7) |
subtype4 | 3 | 1998.0 (10.5) |
subtype5 | 7 | 2002.0 (7.7) |
P value = 0.157 (Kruskal-Wallis (anova)), Q value = 0.47
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 93 | 17.4 (14.1) |
subtype1 | 18 | 14.7 (11.6) |
subtype2 | 36 | 19.9 (17.8) |
subtype3 | 21 | 20.2 (10.9) |
subtype4 | 5 | 7.7 (8.3) |
subtype5 | 13 | 13.4 (9.5) |
P value = 0.669 (Kruskal-Wallis (anova)), Q value = 0.85
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 263 | 1.8 (1.1) |
subtype1 | 55 | 1.7 (1.1) |
subtype2 | 85 | 1.9 (1.2) |
subtype3 | 63 | 1.8 (1.1) |
subtype4 | 22 | 1.6 (1.0) |
subtype5 | 38 | 2.0 (1.3) |
P value = 0.764 (Kruskal-Wallis (anova)), Q value = 0.89
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 85 | 21.1 (7.7) |
subtype1 | 17 | 19.8 (4.7) |
subtype2 | 32 | 21.9 (8.9) |
subtype3 | 16 | 21.6 (6.9) |
subtype4 | 5 | 24.8 (10.1) |
subtype5 | 15 | 19.5 (8.0) |
P value = 0.858 (Fisher's exact test), Q value = 0.93
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 29 | 3 |
subtype1 | 3 | 0 |
subtype2 | 7 | 0 |
subtype3 | 9 | 1 |
subtype4 | 2 | 0 |
subtype5 | 8 | 2 |
P value = 0.0673 (Kruskal-Wallis (anova)), Q value = 0.29
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 267 | 3.6 (2.6) |
subtype1 | 54 | 2.9 (1.9) |
subtype2 | 88 | 4.2 (3.2) |
subtype3 | 63 | 3.6 (2.0) |
subtype4 | 20 | 3.7 (2.2) |
subtype5 | 42 | 3.2 (2.6) |
P value = 0.481 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 112 | 0.1 (0.3) |
subtype1 | 20 | 0.1 (0.2) |
subtype2 | 27 | 0.0 (0.2) |
subtype3 | 39 | 0.2 (0.5) |
subtype4 | 9 | 0.0 (0.0) |
subtype5 | 17 | 0.0 (0.0) |
P value = 0.179 (Kruskal-Wallis (anova)), Q value = 0.49
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 147 | 0.5 (0.9) |
subtype1 | 23 | 0.7 (0.9) |
subtype2 | 41 | 0.7 (1.3) |
subtype3 | 47 | 0.4 (0.7) |
subtype4 | 12 | 0.3 (0.7) |
subtype5 | 24 | 0.5 (0.7) |
P value = 0.016 (Kruskal-Wallis (anova)), Q value = 0.16
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 262 | 2.8 (2.0) |
subtype1 | 52 | 2.2 (1.8) |
subtype2 | 83 | 3.3 (2.4) |
subtype3 | 66 | 2.7 (1.6) |
subtype4 | 21 | 3.2 (1.9) |
subtype5 | 40 | 2.6 (2.2) |
P value = 0.936 (Kruskal-Wallis (anova)), Q value = 0.98
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 122 | 0.9 (1.8) |
subtype1 | 22 | 0.5 (0.7) |
subtype2 | 31 | 1.5 (3.1) |
subtype3 | 41 | 0.7 (1.1) |
subtype4 | 9 | 0.7 (1.4) |
subtype5 | 19 | 0.6 (0.9) |
P value = 0.958 (Kruskal-Wallis (anova)), Q value = 0.99
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 0.1 (0.3) |
subtype1 | 19 | 0.1 (0.3) |
subtype2 | 30 | 0.1 (0.3) |
subtype3 | 41 | 0.1 (0.4) |
subtype4 | 9 | 0.1 (0.3) |
subtype5 | 17 | 0.1 (0.2) |
P value = 0.428 (Fisher's exact test), Q value = 0.72
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 2 | 8 | 40 | 1 | 12 |
subtype1 | 2 | 0 | 7 | 0 | 2 |
subtype2 | 0 | 3 | 8 | 1 | 4 |
subtype3 | 0 | 3 | 16 | 0 | 5 |
subtype4 | 0 | 0 | 2 | 0 | 0 |
subtype5 | 0 | 2 | 7 | 0 | 1 |
P value = 0.0134 (Fisher's exact test), Q value = 0.14
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 25 | 84 | 125 |
subtype1 | 0 | 5 | 16 | 30 |
subtype2 | 1 | 9 | 29 | 37 |
subtype3 | 1 | 5 | 30 | 23 |
subtype4 | 0 | 4 | 5 | 9 |
subtype5 | 1 | 2 | 4 | 26 |
P value = 0.378 (Fisher's exact test), Q value = 0.68
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 72 | 80 |
subtype1 | 21 | 16 |
subtype2 | 17 | 24 |
subtype3 | 19 | 29 |
subtype4 | 5 | 3 |
subtype5 | 10 | 8 |
P value = 0.134 (Kruskal-Wallis (anova)), Q value = 0.42
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 159 | 1.0 (2.4) |
subtype1 | 40 | 0.6 (1.9) |
subtype2 | 40 | 1.7 (3.1) |
subtype3 | 50 | 1.0 (1.9) |
subtype4 | 8 | 0.4 (0.7) |
subtype5 | 21 | 0.9 (3.1) |
P value = 0.319 (Kruskal-Wallis (anova)), Q value = 0.63
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 180 | 22.3 (12.6) |
subtype1 | 43 | 21.8 (10.6) |
subtype2 | 48 | 20.6 (12.0) |
subtype3 | 55 | 24.6 (14.6) |
subtype4 | 10 | 15.9 (8.3) |
subtype5 | 24 | 23.8 (12.7) |
P value = 0.123 (Fisher's exact test), Q value = 0.41
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 55 | 120 |
subtype1 | 0 | 11 |
subtype2 | 21 | 46 |
subtype3 | 20 | 34 |
subtype4 | 4 | 12 |
subtype5 | 10 | 17 |
P value = 0.0235 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 305 | 2008.3 (4.8) |
subtype1 | 59 | 2009.4 (4.0) |
subtype2 | 102 | 2008.9 (4.3) |
subtype3 | 73 | 2007.3 (5.0) |
subtype4 | 26 | 2008.0 (5.9) |
subtype5 | 45 | 2007.5 (5.1) |
P value = 0.317 (Fisher's exact test), Q value = 0.63
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 15 | 54 | 90 |
subtype1 | 6 | 14 | 18 |
subtype2 | 4 | 17 | 33 |
subtype3 | 1 | 14 | 19 |
subtype4 | 0 | 5 | 7 |
subtype5 | 4 | 4 | 13 |
P value = 0.686 (Kruskal-Wallis (anova)), Q value = 0.85
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 264 | 161.0 (7.3) |
subtype1 | 52 | 161.1 (7.2) |
subtype2 | 92 | 160.7 (7.6) |
subtype3 | 62 | 160.5 (7.5) |
subtype4 | 21 | 160.1 (7.4) |
subtype5 | 37 | 162.7 (6.3) |
P value = 0.339 (Fisher's exact test), Q value = 0.65
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 99 | 19 |
subtype1 | 27 | 4 |
subtype2 | 22 | 5 |
subtype3 | 32 | 8 |
subtype4 | 5 | 2 |
subtype5 | 13 | 0 |
P value = 0.458 (Fisher's exact test), Q value = 0.74
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 7 | 104 | 2 |
subtype1 | 2 | 18 | 1 |
subtype2 | 2 | 36 | 0 |
subtype3 | 2 | 20 | 0 |
subtype4 | 1 | 8 | 0 |
subtype5 | 0 | 22 | 1 |
P value = 0.242 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 17 | 13.2 (7.2) |
subtype1 | 1 | 7.1 (NA) |
subtype2 | 5 | 15.8 (8.6) |
subtype3 | 8 | 10.5 (5.5) |
subtype5 | 3 | 18.4 (7.3) |
P value = 9.35e-05 (Kruskal-Wallis (anova)), Q value = 0.003
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 307 | 48.3 (13.8) |
subtype1 | 60 | 46.5 (12.5) |
subtype2 | 102 | 50.4 (14.3) |
subtype3 | 74 | 51.2 (14.1) |
subtype4 | 26 | 50.4 (11.4) |
subtype5 | 45 | 39.7 (11.6) |
P value = 0.00075 (Fisher's exact test), Q value = 0.019
nPatients | STAGE I | STAGE IA | STAGE IA1 | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 5 | 1 | 1 | 1 | 38 | 78 | 39 | 5 | 9 | 5 | 7 | 44 | 1 | 3 | 42 | 9 | 12 |
subtype1 | 1 | 0 | 0 | 0 | 5 | 26 | 9 | 1 | 2 | 1 | 0 | 5 | 0 | 0 | 6 | 1 | 3 |
subtype2 | 2 | 0 | 0 | 0 | 7 | 17 | 12 | 3 | 1 | 0 | 3 | 18 | 0 | 3 | 19 | 5 | 6 |
subtype3 | 0 | 1 | 1 | 1 | 13 | 25 | 8 | 1 | 2 | 1 | 1 | 5 | 0 | 0 | 11 | 2 | 1 |
subtype4 | 2 | 0 | 0 | 0 | 6 | 1 | 2 | 0 | 1 | 1 | 2 | 5 | 1 | 0 | 3 | 0 | 2 |
subtype5 | 0 | 0 | 0 | 0 | 7 | 9 | 8 | 0 | 3 | 2 | 1 | 11 | 0 | 0 | 3 | 1 | 0 |
Cluster Labels | 1 | 2 | 3 |
---|---|---|---|
Number of samples | 104 | 82 | 108 |
P value = 0.779 (logrank test), Q value = 0.89
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 283 | 69 | 0.1 - 210.7 (23.8) |
subtype1 | 102 | 20 | 0.3 - 210.7 (20.4) |
subtype2 | 78 | 19 | 0.1 - 155.8 (20.8) |
subtype3 | 103 | 30 | 0.1 - 177.0 (28.5) |
P value = 0.0366 (Kruskal-Wallis (anova)), Q value = 0.21
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 293 | 48.2 (13.8) |
subtype1 | 104 | 49.6 (13.1) |
subtype2 | 81 | 50.0 (14.3) |
subtype3 | 108 | 45.4 (13.8) |
P value = 0.211 (Fisher's exact test), Q value = 0.54
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 136 | 68 | 19 | 9 |
subtype1 | 44 | 25 | 10 | 5 |
subtype2 | 44 | 13 | 3 | 2 |
subtype3 | 48 | 30 | 6 | 2 |
P value = 0.547 (Fisher's exact test), Q value = 0.79
nPatients | 0 | 1 |
---|---|---|
ALL | 130 | 57 |
subtype1 | 42 | 14 |
subtype2 | 42 | 20 |
subtype3 | 46 | 23 |
P value = 0.114 (Fisher's exact test), Q value = 0.4
nPatients | 0 | 1 |
---|---|---|
ALL | 112 | 9 |
subtype1 | 32 | 6 |
subtype2 | 36 | 1 |
subtype3 | 44 | 2 |
P value = 0.976 (Fisher's exact test), Q value = 1
nPatients | NO | YES |
---|---|---|
ALL | 53 | 124 |
subtype1 | 22 | 51 |
subtype2 | 12 | 26 |
subtype3 | 19 | 47 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 6 | 242 | 6 | 20 | 3 | 17 |
subtype1 | 5 | 65 | 4 | 14 | 3 | 13 |
subtype2 | 1 | 69 | 2 | 6 | 0 | 4 |
subtype3 | 0 | 108 | 0 | 0 | 0 | 0 |
P value = 0.302 (Kruskal-Wallis (anova)), Q value = 0.62
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 88 | 17.2 (14.0) |
subtype1 | 28 | 15.4 (13.6) |
subtype2 | 26 | 19.4 (12.2) |
subtype3 | 34 | 16.9 (15.7) |
P value = 0.478 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 155 | 1.0 (2.3) |
subtype1 | 45 | 0.7 (2.2) |
subtype2 | 54 | 1.2 (2.4) |
subtype3 | 56 | 1.0 (2.5) |
P value = 0.0823 (Fisher's exact test), Q value = 0.33
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 7 | 19 | 27 | 2 | 205 |
subtype1 | 1 | 7 | 13 | 0 | 69 |
subtype2 | 1 | 8 | 3 | 0 | 60 |
subtype3 | 5 | 4 | 11 | 2 | 76 |
P value = 0.24 (Fisher's exact test), Q value = 0.55
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 24 | 161 |
subtype1 | 8 | 53 |
subtype2 | 4 | 52 |
subtype3 | 12 | 56 |
P value = 0.476 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 266 | 72.9 (21.4) |
subtype1 | 96 | 73.7 (20.6) |
subtype2 | 74 | 72.3 (27.6) |
subtype3 | 96 | 72.6 (16.5) |
P value = 0.556 (Fisher's exact test), Q value = 0.8
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 194 | 75 |
subtype1 | 64 | 30 |
subtype2 | 55 | 20 |
subtype3 | 75 | 25 |
P value = 0.00354 (Fisher's exact test), Q value = 0.073
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 16 | 128 | 118 | 1 | 23 |
subtype1 | 5 | 37 | 47 | 0 | 13 |
subtype2 | 9 | 43 | 29 | 0 | 1 |
subtype3 | 2 | 48 | 42 | 1 | 9 |
P value = 0.422 (Kruskal-Wallis (anova)), Q value = 0.72
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 41 | 2000.0 (13.9) |
subtype1 | 16 | 2001.9 (15.9) |
subtype2 | 9 | 1996.2 (16.2) |
subtype3 | 16 | 2000.1 (10.5) |
P value = 0.302 (Kruskal-Wallis (anova)), Q value = 0.62
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 88 | 17.2 (14.0) |
subtype1 | 28 | 15.4 (13.6) |
subtype2 | 26 | 19.4 (12.2) |
subtype3 | 34 | 16.9 (15.7) |
P value = 0.444 (Kruskal-Wallis (anova)), Q value = 0.73
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 255 | 1.8 (1.1) |
subtype1 | 89 | 1.8 (1.2) |
subtype2 | 70 | 1.9 (1.2) |
subtype3 | 96 | 1.9 (1.2) |
P value = 0.95 (Kruskal-Wallis (anova)), Q value = 0.99
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 80 | 20.9 (7.6) |
subtype1 | 26 | 21.0 (6.9) |
subtype2 | 22 | 20.2 (6.8) |
subtype3 | 32 | 21.2 (8.7) |
P value = 1 (Fisher's exact test), Q value = 1
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 27 | 3 |
subtype1 | 5 | 0 |
subtype2 | 6 | 1 |
subtype3 | 16 | 2 |
P value = 0.494 (Kruskal-Wallis (anova)), Q value = 0.76
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 257 | 3.6 (2.5) |
subtype1 | 90 | 3.4 (2.5) |
subtype2 | 74 | 3.7 (2.3) |
subtype3 | 93 | 3.7 (2.7) |
P value = 0.756 (Kruskal-Wallis (anova)), Q value = 0.89
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 107 | 0.1 (0.3) |
subtype1 | 24 | 0.0 (0.2) |
subtype2 | 35 | 0.0 (0.2) |
subtype3 | 48 | 0.1 (0.5) |
P value = 0.194 (Kruskal-Wallis (anova)), Q value = 0.51
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 0.6 (1.0) |
subtype1 | 37 | 0.8 (1.3) |
subtype2 | 47 | 0.4 (0.7) |
subtype3 | 59 | 0.5 (0.9) |
P value = 0.957 (Kruskal-Wallis (anova)), Q value = 0.99
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 252 | 2.8 (2.0) |
subtype1 | 87 | 2.8 (2.1) |
subtype2 | 73 | 2.8 (1.9) |
subtype3 | 92 | 2.9 (2.1) |
P value = 0.188 (Kruskal-Wallis (anova)), Q value = 0.51
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 0.8 (1.8) |
subtype1 | 27 | 0.7 (1.0) |
subtype2 | 40 | 1.1 (2.2) |
subtype3 | 49 | 0.6 (1.7) |
P value = 0.982 (Kruskal-Wallis (anova)), Q value = 1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 112 | 0.1 (0.3) |
subtype1 | 26 | 0.1 (0.3) |
subtype2 | 37 | 0.1 (0.4) |
subtype3 | 49 | 0.1 (0.3) |
P value = 0.397 (Fisher's exact test), Q value = 0.7
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 1 | 7 | 39 | 1 | 12 |
subtype1 | 1 | 1 | 8 | 0 | 2 |
subtype2 | 0 | 3 | 12 | 1 | 7 |
subtype3 | 0 | 3 | 19 | 0 | 3 |
P value = 0.012 (Fisher's exact test), Q value = 0.14
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 25 | 78 | 120 |
subtype1 | 1 | 15 | 26 | 39 |
subtype2 | 0 | 6 | 29 | 28 |
subtype3 | 2 | 4 | 23 | 53 |
P value = 0.695 (Fisher's exact test), Q value = 0.86
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 69 | 74 |
subtype1 | 20 | 25 |
subtype2 | 23 | 26 |
subtype3 | 26 | 23 |
P value = 0.478 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 155 | 1.0 (2.3) |
subtype1 | 45 | 0.7 (2.2) |
subtype2 | 54 | 1.2 (2.4) |
subtype3 | 56 | 1.0 (2.5) |
P value = 0.642 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 172 | 22.7 (12.6) |
subtype1 | 52 | 20.8 (11.4) |
subtype2 | 60 | 23.5 (12.8) |
subtype3 | 60 | 23.5 (13.5) |
P value = 0.00884 (Fisher's exact test), Q value = 0.11
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 52 | 114 |
subtype1 | 5 | 34 |
subtype2 | 21 | 30 |
subtype3 | 26 | 50 |
P value = 0.00872 (Kruskal-Wallis (anova)), Q value = 0.11
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 292 | 2008.3 (4.8) |
subtype1 | 103 | 2009.3 (4.4) |
subtype2 | 81 | 2008.2 (4.7) |
subtype3 | 108 | 2007.5 (5.1) |
P value = 0.625 (Fisher's exact test), Q value = 0.84
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 15 | 54 | 85 |
subtype1 | 6 | 20 | 33 |
subtype2 | 3 | 18 | 19 |
subtype3 | 6 | 16 | 33 |
P value = 0.708 (Kruskal-Wallis (anova)), Q value = 0.86
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 253 | 160.8 (7.3) |
subtype1 | 91 | 160.8 (6.5) |
subtype2 | 69 | 160.9 (8.2) |
subtype3 | 93 | 160.8 (7.4) |
P value = 0.857 (Fisher's exact test), Q value = 0.93
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 95 | 19 |
subtype1 | 28 | 6 |
subtype2 | 31 | 7 |
subtype3 | 36 | 6 |
P value = 0.895 (Fisher's exact test), Q value = 0.96
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 7 | 102 | 2 |
subtype1 | 3 | 37 | 1 |
subtype2 | 2 | 19 | 0 |
subtype3 | 2 | 46 | 1 |
P value = 0.18 (Kruskal-Wallis (anova)), Q value = 0.49
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 16 | 13.0 (7.3) |
subtype1 | 3 | 16.8 (11.0) |
subtype2 | 7 | 9.0 (5.4) |
subtype3 | 6 | 15.7 (6.1) |
P value = 0.0326 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 294 | 48.2 (13.8) |
subtype1 | 104 | 49.6 (13.1) |
subtype2 | 82 | 50.1 (14.2) |
subtype3 | 108 | 45.4 (13.8) |
P value = 0.0295 (Fisher's exact test), Q value = 0.2
nPatients | STAGE I | STAGE IA | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 5 | 1 | 1 | 37 | 76 | 37 | 5 | 8 | 5 | 7 | 42 | 3 | 41 | 8 | 11 |
subtype1 | 3 | 0 | 0 | 8 | 29 | 16 | 2 | 2 | 1 | 3 | 11 | 2 | 14 | 2 | 7 |
subtype2 | 0 | 1 | 1 | 7 | 27 | 11 | 2 | 3 | 1 | 2 | 6 | 0 | 13 | 4 | 1 |
subtype3 | 2 | 0 | 0 | 22 | 20 | 10 | 1 | 3 | 3 | 2 | 25 | 1 | 14 | 2 | 3 |
Cluster Labels | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
Number of samples | 29 | 81 | 109 | 42 | 33 |
P value = 0.928 (logrank test), Q value = 0.98
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 283 | 69 | 0.1 - 210.7 (23.8) |
subtype1 | 28 | 5 | 0.5 - 137.2 (19.3) |
subtype2 | 78 | 20 | 0.1 - 177.0 (23.8) |
subtype3 | 105 | 24 | 0.1 - 210.7 (24.3) |
subtype4 | 40 | 11 | 0.4 - 154.3 (23.6) |
subtype5 | 32 | 9 | 0.5 - 97.0 (19.6) |
P value = 0.00654 (Kruskal-Wallis (anova)), Q value = 0.1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 293 | 48.2 (13.8) |
subtype1 | 29 | 48.7 (10.1) |
subtype2 | 81 | 50.6 (14.5) |
subtype3 | 108 | 49.9 (14.2) |
subtype4 | 42 | 40.8 (11.7) |
subtype5 | 33 | 45.9 (13.2) |
P value = 0.262 (Fisher's exact test), Q value = 0.57
nPatients | T1 | T2 | T3 | T4 |
---|---|---|---|---|
ALL | 136 | 68 | 19 | 9 |
subtype1 | 13 | 12 | 1 | 1 |
subtype2 | 42 | 13 | 3 | 2 |
subtype3 | 43 | 31 | 10 | 4 |
subtype4 | 18 | 6 | 4 | 1 |
subtype5 | 20 | 6 | 1 | 1 |
P value = 0.0778 (Fisher's exact test), Q value = 0.32
nPatients | 0 | 1 |
---|---|---|
ALL | 130 | 57 |
subtype1 | 18 | 2 |
subtype2 | 42 | 17 |
subtype3 | 37 | 26 |
subtype4 | 15 | 7 |
subtype5 | 18 | 5 |
P value = 0.282 (Fisher's exact test), Q value = 0.6
nPatients | 0 | 1 |
---|---|---|
ALL | 112 | 9 |
subtype1 | 15 | 3 |
subtype2 | 40 | 1 |
subtype3 | 35 | 4 |
subtype4 | 14 | 1 |
subtype5 | 8 | 0 |
P value = 0.927 (Fisher's exact test), Q value = 0.98
nPatients | NO | YES |
---|---|---|
ALL | 53 | 124 |
subtype1 | 7 | 14 |
subtype2 | 11 | 23 |
subtype3 | 19 | 53 |
subtype4 | 9 | 19 |
subtype5 | 7 | 15 |
P value = 1e-05 (Fisher's exact test), Q value = 0.00043
nPatients | ADENOSQUAMOUS | CERVICAL SQUAMOUS CELL CARCINOMA | ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE | ENDOCERVICAL TYPE OF ADENOCARCINOMA | ENDOMETRIOID ADENOCARCINOMA OF ENDOCERVIX | MUCINOUS ADENOCARCINOMA OF ENDOCERVICAL TYPE |
---|---|---|---|---|---|---|
ALL | 6 | 242 | 6 | 20 | 3 | 17 |
subtype1 | 3 | 15 | 1 | 5 | 2 | 3 |
subtype2 | 1 | 78 | 0 | 1 | 0 | 1 |
subtype3 | 1 | 105 | 1 | 2 | 0 | 0 |
subtype4 | 0 | 42 | 0 | 0 | 0 | 0 |
subtype5 | 1 | 2 | 4 | 12 | 1 | 13 |
P value = 0.0646 (Kruskal-Wallis (anova)), Q value = 0.29
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 88 | 17.2 (14.0) |
subtype1 | 5 | 12.2 (9.9) |
subtype2 | 23 | 20.7 (10.4) |
subtype3 | 36 | 19.4 (17.1) |
subtype4 | 13 | 10.5 (9.9) |
subtype5 | 11 | 12.9 (12.4) |
P value = 0.0318 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 155 | 1.0 (2.3) |
subtype1 | 15 | 0.1 (0.5) |
subtype2 | 51 | 0.9 (1.9) |
subtype3 | 52 | 1.6 (3.1) |
subtype4 | 15 | 0.3 (0.6) |
subtype5 | 22 | 0.8 (2.4) |
P value = 0.0739 (Fisher's exact test), Q value = 0.31
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 7 | 19 | 27 | 2 | 205 |
subtype1 | 1 | 4 | 2 | 0 | 17 |
subtype2 | 1 | 9 | 4 | 0 | 59 |
subtype3 | 3 | 4 | 13 | 1 | 74 |
subtype4 | 2 | 2 | 7 | 1 | 27 |
subtype5 | 0 | 0 | 1 | 0 | 28 |
P value = 0.217 (Fisher's exact test), Q value = 0.55
nPatients | HISPANIC OR LATINO | NOT HISPANIC OR LATINO |
---|---|---|
ALL | 24 | 161 |
subtype1 | 3 | 16 |
subtype2 | 3 | 55 |
subtype3 | 10 | 52 |
subtype4 | 5 | 22 |
subtype5 | 3 | 16 |
P value = 0.479 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 266 | 72.9 (21.4) |
subtype1 | 28 | 73.5 (18.5) |
subtype2 | 72 | 72.0 (28.3) |
subtype3 | 102 | 72.9 (19.9) |
subtype4 | 36 | 74.8 (16.7) |
subtype5 | 28 | 72.4 (14.8) |
P value = 0.642 (Fisher's exact test), Q value = 0.84
nPatients | TUMOR FREE | WITH TUMOR |
---|---|---|
ALL | 194 | 75 |
subtype1 | 17 | 11 |
subtype2 | 54 | 21 |
subtype3 | 73 | 27 |
subtype4 | 29 | 8 |
subtype5 | 21 | 8 |
P value = 6e-05 (Fisher's exact test), Q value = 0.0021
nPatients | G1 | G2 | G3 | G4 | GX |
---|---|---|---|---|---|
ALL | 16 | 128 | 118 | 1 | 23 |
subtype1 | 1 | 6 | 18 | 0 | 4 |
subtype2 | 7 | 39 | 32 | 0 | 2 |
subtype3 | 3 | 52 | 39 | 1 | 10 |
subtype4 | 0 | 10 | 24 | 0 | 5 |
subtype5 | 5 | 21 | 5 | 0 | 2 |
P value = 0.479 (Kruskal-Wallis (anova)), Q value = 0.74
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 41 | 2000.0 (13.9) |
subtype1 | 2 | 2003.5 (4.9) |
subtype2 | 9 | 1996.1 (11.6) |
subtype3 | 18 | 2000.8 (16.5) |
subtype4 | 6 | 2002.0 (11.5) |
subtype5 | 6 | 2000.0 (15.0) |
P value = 0.0646 (Kruskal-Wallis (anova)), Q value = 0.29
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 88 | 17.2 (14.0) |
subtype1 | 5 | 12.2 (9.9) |
subtype2 | 23 | 20.7 (10.4) |
subtype3 | 36 | 19.4 (17.1) |
subtype4 | 13 | 10.5 (9.9) |
subtype5 | 11 | 12.9 (12.4) |
P value = 0.31 (Kruskal-Wallis (anova)), Q value = 0.63
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 255 | 1.8 (1.1) |
subtype1 | 25 | 1.4 (0.9) |
subtype2 | 68 | 1.8 (1.1) |
subtype3 | 98 | 1.9 (1.2) |
subtype4 | 33 | 1.8 (1.2) |
subtype5 | 31 | 1.8 (1.2) |
P value = 0.4 (Kruskal-Wallis (anova)), Q value = 0.7
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 80 | 20.9 (7.6) |
subtype1 | 4 | 26.5 (6.6) |
subtype2 | 19 | 20.2 (4.8) |
subtype3 | 34 | 21.3 (8.8) |
subtype4 | 12 | 20.3 (9.8) |
subtype5 | 11 | 19.5 (4.5) |
P value = 0.0332 (Fisher's exact test), Q value = 0.2
nPatients | COMPLETED AS PLANNED | TREATMENT NOT COMPLETED |
---|---|---|
ALL | 27 | 3 |
subtype1 | 0 | 0 |
subtype2 | 8 | 1 |
subtype3 | 16 | 0 |
subtype4 | 2 | 2 |
subtype5 | 1 | 0 |
P value = 0.0979 (Kruskal-Wallis (anova)), Q value = 0.37
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 257 | 3.6 (2.5) |
subtype1 | 27 | 2.7 (2.1) |
subtype2 | 70 | 3.7 (2.1) |
subtype3 | 96 | 3.9 (2.9) |
subtype4 | 35 | 3.4 (2.6) |
subtype5 | 29 | 3.1 (2.1) |
P value = 0.657 (Kruskal-Wallis (anova)), Q value = 0.84
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 107 | 0.1 (0.3) |
subtype1 | 7 | 0.0 (0.0) |
subtype2 | 38 | 0.1 (0.5) |
subtype3 | 38 | 0.1 (0.2) |
subtype4 | 10 | 0.0 (0.0) |
subtype5 | 14 | 0.0 (0.0) |
P value = 0.159 (Kruskal-Wallis (anova)), Q value = 0.48
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 143 | 0.6 (1.0) |
subtype1 | 9 | 0.4 (0.5) |
subtype2 | 47 | 0.3 (0.5) |
subtype3 | 54 | 0.8 (1.3) |
subtype4 | 16 | 0.6 (0.7) |
subtype5 | 17 | 0.7 (1.0) |
P value = 0.235 (Kruskal-Wallis (anova)), Q value = 0.55
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 252 | 2.8 (2.0) |
subtype1 | 24 | 2.4 (1.8) |
subtype2 | 73 | 2.7 (1.4) |
subtype3 | 93 | 3.1 (2.2) |
subtype4 | 33 | 2.9 (2.4) |
subtype5 | 29 | 2.4 (2.1) |
P value = 0.323 (Kruskal-Wallis (anova)), Q value = 0.64
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 116 | 0.8 (1.8) |
subtype1 | 8 | 1.0 (1.4) |
subtype2 | 41 | 1.1 (2.2) |
subtype3 | 40 | 0.6 (1.7) |
subtype4 | 12 | 0.8 (1.0) |
subtype5 | 15 | 0.4 (0.6) |
P value = 0.426 (Kruskal-Wallis (anova)), Q value = 0.72
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 112 | 0.1 (0.3) |
subtype1 | 7 | 0.0 (0.0) |
subtype2 | 40 | 0.1 (0.4) |
subtype3 | 41 | 0.2 (0.4) |
subtype4 | 10 | 0.0 (0.0) |
subtype5 | 14 | 0.1 (0.3) |
P value = 0.261 (Fisher's exact test), Q value = 0.57
nPatients | MACROSCOPIC PARAMETRIAL INVOLVEMENT | MICROSCOPIC PARAMETRIAL INVOLVEMENT | OTHER LOCATION, SPECIFY | POSITIVE BLADDER MARGIN | POSITIVE VAGINAL MARGIN |
---|---|---|---|---|---|
ALL | 1 | 7 | 39 | 1 | 12 |
subtype1 | 1 | 0 | 1 | 0 | 1 |
subtype2 | 0 | 1 | 15 | 1 | 5 |
subtype3 | 0 | 5 | 12 | 0 | 5 |
subtype4 | 0 | 1 | 5 | 0 | 0 |
subtype5 | 0 | 0 | 6 | 0 | 1 |
P value = 0.29 (Fisher's exact test), Q value = 0.61
nPatients | INDETERMINATE (NEITHER PRE OR POSTMENOPAUSAL) | PERI (6-12 MONTHS SINCE LAST MENSTRUAL PERIOD) | POST (PRIOR BILATERAL OVARIECTOMY OR >12 MO SINCE LMP WITH NO PRIOR HYSTERECTOMY) | PRE (<6 MONTHS SINCE LMP AND NO PRIOR BILATERAL OVARIECTOMY AND NOT ON ESTROGEN REPLACEMENT) |
---|---|---|---|---|
ALL | 3 | 25 | 78 | 120 |
subtype1 | 0 | 3 | 6 | 16 |
subtype2 | 1 | 5 | 29 | 27 |
subtype3 | 1 | 11 | 30 | 43 |
subtype4 | 1 | 3 | 4 | 19 |
subtype5 | 0 | 3 | 9 | 15 |
P value = 0.112 (Fisher's exact test), Q value = 0.4
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 69 | 74 |
subtype1 | 6 | 12 |
subtype2 | 25 | 27 |
subtype3 | 19 | 25 |
subtype4 | 6 | 6 |
subtype5 | 13 | 4 |
P value = 0.0318 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 155 | 1.0 (2.3) |
subtype1 | 15 | 0.1 (0.5) |
subtype2 | 51 | 0.9 (1.9) |
subtype3 | 52 | 1.6 (3.1) |
subtype4 | 15 | 0.3 (0.6) |
subtype5 | 22 | 0.8 (2.4) |
P value = 0.316 (Kruskal-Wallis (anova)), Q value = 0.63
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 172 | 22.7 (12.6) |
subtype1 | 18 | 19.1 (9.9) |
subtype2 | 57 | 24.1 (14.2) |
subtype3 | 56 | 20.9 (12.2) |
subtype4 | 18 | 24.9 (13.2) |
subtype5 | 23 | 24.7 (10.7) |
P value = 0.0641 (Fisher's exact test), Q value = 0.29
nPatients | KERATINIZING SQUAMOUS CELL CARCINOMA | NON-KERATINIZING SQUAMOUS CELL CARCINOMA |
---|---|---|
ALL | 52 | 114 |
subtype1 | 0 | 10 |
subtype2 | 23 | 35 |
subtype3 | 19 | 46 |
subtype4 | 10 | 19 |
subtype5 | 0 | 4 |
P value = 0.0245 (Kruskal-Wallis (anova)), Q value = 0.2
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 292 | 2008.3 (4.8) |
subtype1 | 29 | 2010.7 (2.5) |
subtype2 | 80 | 2007.4 (5.3) |
subtype3 | 109 | 2008.7 (4.6) |
subtype4 | 42 | 2007.3 (5.2) |
subtype5 | 32 | 2008.6 (4.2) |
P value = 0.662 (Fisher's exact test), Q value = 0.84
nPatients | CURRENT USER | FORMER USER | NEVER USED |
---|---|---|---|
ALL | 15 | 54 | 85 |
subtype1 | 4 | 6 | 8 |
subtype2 | 2 | 13 | 22 |
subtype3 | 4 | 21 | 35 |
subtype4 | 2 | 6 | 11 |
subtype5 | 3 | 8 | 9 |
P value = 0.437 (Kruskal-Wallis (anova)), Q value = 0.72
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 253 | 160.8 (7.3) |
subtype1 | 28 | 160.1 (4.9) |
subtype2 | 66 | 160.1 (7.8) |
subtype3 | 98 | 160.6 (7.2) |
subtype4 | 34 | 162.0 (7.7) |
subtype5 | 27 | 162.4 (8.2) |
P value = 0.359 (Fisher's exact test), Q value = 0.66
nPatients | ABSENT | PRESENT |
---|---|---|
ALL | 95 | 19 |
subtype1 | 10 | 4 |
subtype2 | 34 | 9 |
subtype3 | 28 | 5 |
subtype4 | 8 | 0 |
subtype5 | 15 | 1 |
P value = 0.08 (Fisher's exact test), Q value = 0.32
nPatients | CARBOPLATIN | CISPLATIN | OTHER |
---|---|---|---|
ALL | 7 | 102 | 2 |
subtype1 | 2 | 9 | 0 |
subtype2 | 2 | 19 | 0 |
subtype3 | 1 | 48 | 0 |
subtype4 | 1 | 16 | 1 |
subtype5 | 1 | 10 | 1 |
P value = 0.19 (Kruskal-Wallis (anova)), Q value = 0.51
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 16 | 13.0 (7.3) |
subtype1 | 1 | 7.1 (NA) |
subtype2 | 7 | 9.5 (5.2) |
subtype3 | 5 | 15.8 (8.6) |
subtype4 | 3 | 18.2 (7.3) |
P value = 0.00599 (Kruskal-Wallis (anova)), Q value = 0.1
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 294 | 48.2 (13.8) |
subtype1 | 29 | 48.7 (10.1) |
subtype2 | 81 | 50.6 (14.5) |
subtype3 | 109 | 49.9 (14.2) |
subtype4 | 42 | 40.8 (11.7) |
subtype5 | 33 | 45.9 (13.2) |
P value = 0.514 (Fisher's exact test), Q value = 0.78
nPatients | STAGE I | STAGE IA | STAGE IA2 | STAGE IB | STAGE IB1 | STAGE IB2 | STAGE II | STAGE IIA | STAGE IIA1 | STAGE IIA2 | STAGE IIB | STAGE IIIA | STAGE IIIB | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 5 | 1 | 1 | 37 | 76 | 37 | 5 | 8 | 5 | 7 | 42 | 3 | 41 | 8 | 11 |
subtype1 | 1 | 0 | 0 | 2 | 8 | 5 | 0 | 2 | 1 | 2 | 4 | 0 | 2 | 0 | 2 |
subtype2 | 0 | 1 | 1 | 14 | 22 | 9 | 3 | 2 | 2 | 2 | 7 | 0 | 13 | 3 | 1 |
subtype3 | 3 | 0 | 0 | 11 | 24 | 10 | 2 | 1 | 2 | 3 | 20 | 1 | 18 | 3 | 6 |
subtype4 | 1 | 0 | 0 | 7 | 7 | 7 | 0 | 2 | 0 | 0 | 8 | 2 | 5 | 1 | 1 |
subtype5 | 0 | 0 | 0 | 3 | 15 | 6 | 0 | 1 | 0 | 0 | 3 | 0 | 3 | 1 | 1 |
-
Cluster data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_mergedClustering/CESC-TP/22541064/CESC-TP.mergedcluster.txt
-
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/CESC-TP/22489370/CESC-TP.merged_data.txt
-
Number of patients = 307
-
Number of clustering approaches = 10
-
Number of selected clinical features = 39
-
Exclude small clusters that include fewer than K patients, K = 3
consensus non-negative matrix factorization clustering approach (Brunet et al. 2004)
Resampling-based clustering method (Monti et al. 2003)
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary clinical features, two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.